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Abstract 
 
Background 
 
Individuals who are latently infected with Mycobacterium tuberculosis (M.tb) are able to 
quell the infection by balancing the innate and adaptive immune responses. Glucocorticoids 
(GCs) can affect this balance and can increase the risk of reactivation of TB. The three month 
injectable contraceptive medroxyprogesterone acetate (MPA) is widely used by women in 
developing countries, where TB is rife. MPA, unlike the two monthly contraceptive 
norethisterone enanthate (NET), possesses selective glucocorticoid activity, and could 
therefore alter immune responses to TB. 
Aims 
 
The aim of my investigation was to elucidate the immune modulatory effects of the synthetic 
progestins, MPA and NET, compared to the endogenous hormones, cortisol and 
progesterone, in Mycobacterium bovis Bacillus Calmette–Guérin (BCG) or anti-CD3 
stimulated peripheral blood mononuclear cells (PBMC).  I aim to determine the effects of 
MPA, NET, cortisol and progesterone on the receptor expression of glucocorticoid and 
various progesterone receptors. I investigate the effect of the above mentioned hormones on 
the downstream signalling cascades in the presence or absence of either BCG or anti-CD3. 
The overall immune modulation will be determined with regard to the cytokine production in 
PBMCs. 
Methods 
 
The presence of receptors for these steroid hormones in PBMCs was verified and BCG, anti-
CD3 and hormone induced changes in receptor expression determined through RT-PCR. The 
impact of cortisol, MPA, NET and progesterone on BCG or anti-CD3 mediated activation of 
downstream signalling molecules were determined by Western blot as well as Luminex 
analysis.  
Results and Conclusion 
 
My results show that BCG and anti-CD3 mediated activation of the T cell receptor associated 
signalling molecules, Lck, ZAP-70, LAT was inhibited by the steroid hormones. Similarly 
several kinases including JNK, ERK and p38 and transcription factors including STAT3, 
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STAT5 and CREB were differentially affected by the hormones. The inhibition of 
phosphorylation seen in the different signalling molecules indicated an inhibition of 
activation of downstream signalling cascades. To investigate the impact of the hormone 
induced changes in the signalling cascades on the expression of inflammatory and anti-
inflammatory cytokines Luminex analysis was performed on the supernatant of the BCG and 
anti-CD3 stimulated PBMC cultures. Cortisol and MPA, but not NET and progesterone, 
significantly inhibited the secretion of IL-1α, IL-1β, IL-6, IL-10, TNF-α, IL-12 and IL-13. 
These results suggest that the immune suppressive effects of MPA are likely mediated 
through a combination of direct genomic GR action as well as through direct or indirect 
inhibition of several signalling molecules.  
The inhibition of the IFN-γ, IL-12, IL-1and IL-6 secretion by MPA could potentially increase 
the risk of susceptibility to TB in women using this contraceptive. Therefore the absence of 
glucocorticoid activity seen with NET could make this contraceptive a better choice for 
women in TB endemic areas.  
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Opsomming 
 
Agtergrond 
 
Individue wat latent met Mikobakterium tuberkulose (M.tb) geïnfekteer is, is in staat om die 
infeksie te onderdruk deur die ingebore en aanpasbare immuunrespons te balanseer. 
Glukokortikoïede (GCs) kan hierdie balans beïnvloed en kan die risiko van heraktivering van 
tuberkulose (TB) verhoog. Die drie maande inspuitbare voorbehoedmiddel 
medroksiprogestroon-asetaat (MPA) word algemeen gebruik deur vroue in ontwikkelende 
lande, waar TB volop is. MPA, in teenstelling met die twee maandelikse voorbehoedmiddel 
noretisteroon enantaat (NET), beskik selektiewe glukokortikoïed aktiwiteit, en kan dus die 
immuunrespons teenoor TB verander. 
 
Doelwitte 
 
Die doel van my studie was om die immuunregulerende effekte van die sintetiese 
progestiene, MPA en NET, toe te lig , in vergelyking met die endogene hormone, kortisol en 
progesteroon, in Mycobacterium bovis Bacillus Calmette - Guerin (BCG) of anti- CD3 
gestimuleerde perifere bloed mononukleêre selle (PBMSe). Ek het beoog om die gevolge van 
MPA, NET, kortisol en progesteroon op die reseptor uitdrukking van glukokortikoïede en 
verskeie progesteroon reseptore te bepaal. Ek het ondersoek ingestel op die effek van die 
bogenoemde hormone op die sein transduksie in die teenwoordigheid of afwesigheid van óf 
BCG of anti-CD3. Die algehele immuun -modulasie sal bepaal word met betrekking tot die 
produksie van sitokiene in PBMSe . 
Metodes 
 
Die teenwoordigheid van reseptore vir die steroïedhormone in PBMSe is geverifieer en BCG 
en anti-CD3 en die veranderinge deurdie hormone in verband met die reseptor uitdrukking 
bepaal deur RT -PCR. Die impak van kortisol, MPA, NET en progesteroon op BCG of anti- 
CD3 aktivering van sein transduksie molekules is bepaal deur ‘Western blot’ asook Luminex 
analise. 
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Resultate en gevolgtrekking 
 
My resultate toon dat BCG en anti-CD3 die aktivering van die T-sel reseptor wat verband 
hou met sein molekules , LCK , ZAP -70 , en LAT word geïnhibeer deur die steroïedhormone 
. Van die kinases insluitend JNK , ERK en p38 en transkripsie faktore, insluitend STAT3 , 
STAT5 en CREB is beïnvloed deur die hormone. Die inhibisie van fosforilering gesien in die 
verskillende sein molekules dui daarop aan dat 'n inhibisie van aktivering van sein 
transduksie. Die impak van die hormoon veroorsaak veranderinge in die sein transduksie met 
betrekking tot die uitdrukking van inflammatoriese en anti -inflammatoriese sitokiene 
Luminex analise is uitgevoer op die supernatant van die BCG en anti-CD3 gestimuleerde 
PBMS kulture. Kortisol en MPA, maar nie NET en progesteroon , het aansienlik die 
produksie van IL-1α , IL-1β , IL-6 , IL-10 , TNF-α , IL-12 en IL-13 geïnhibeer. Hierdie 
resultate dui daarop dat die immuunstelsel se onderdrukkende effekte van MPA is 
waarskynlik bemiddel deur 'n kombinasie van direkte genomiese GR interaksie sowel as deur 
direkte of indirekte inhibisie van verskeie sein molekules . 
Die inhibisie van die IFN-γ, IL-12, IL-1 en IL-6 sekresie deur MPA kan potensieel die risiko 
verhoog van vatbaarheid vir TB in vroue wat hierdie voorbehoedmiddel gebruik. Daarom oor 
die afwesigheid van glukokortikoïede aktiwiteit wat gesien is met NET, kan maak laat hierdie 
voorbehoedmiddel 'n beter keuse vir vroue in TB endemiese gebiede. 
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Chapter 1: Introduction 
1.1 Tuberculosis 
 
More than 2 billion people worldwide are latently infected with Mycobacterium tuberculosis 
(M.tb), these amounts to roughly one third of the world’s population (1). Despite the high 
number of recorded M.tb infected individuals, merely 10% of these will convert to active 
disease. 
Tuberculosis is an infectious disease spread through airborne droplets containing M.tb, which 
is introduced to the surrounding air when an individual infected with M.tb coughs or sneezes. 
During 2009 according to the World Health Organisation (WHO) 1.7 million people died 
from TB, 35% of these recorded deaths were among woman infected with M.tb (1). The 
Global Tuberculosis Report 2012 places South Africa in the top five countries with the 
largest number of TB incidence cases in 2011, 1) India (2.0 – 2.5 mill), 2) China (0.9 – 1.1 
mill), 3) South Africa (0.4 – 0.6 mill), 4) Indonesia (0.4 – 0.6 mill) and 5) Pakistan (0.3 – 0.5 
mill). South Africa had 389 974 new TB case notifications in 2011 (1). Figure 1.1 shows that 
Africa is amongst the high incidence regions in the world with regard to TB disease. 
 
Figure 1.1: Estimated TB incident rates as recorded in 2011 by the WHO (1). 
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1.2 Immunology of TB 
 
The M.tb bacilli gain entry into the hosts system through the respiratory tract by the 
inhalation of droplets allowing it to enter the lower respiratory tract. When M.tb bacilli enter 
the lungs they endure four possible fates (2). The initial host response can completely 
eradicate the bacteria so that the patient does not develop TB. Secondly, the bacilli could 
begin to multiply and grow within the host after infection causing clinical disease which is 
known as primary TB. Thirdly, once in the host the bacilli could remain dormant and never 
cause clinical disease. This phenomenon is called latent TB infection and the individuals only 
presents with a positive tuberculin skin test (TST). Lastly, the latent bacilli may begin to 
grow at a later stage resulting in the manifestation of clinical disease referred to as 
reactivation TB (2).  
Upon introduction of an antigen to the host, the body will launch a nonspecific defence 
mechanism, either immediately or within hours after the introduction to the host. This initial 
immune response is known as innate immunity (3). Cells of the innate immune system are 
neutrophils, macrophages and dendritic cells (DC) which phagocytose and kill pathogens. 
The innate immune response contributes to the activation of the adaptive immune response 
through antigen presentation. Antigen presentation and interleukin (IL)-12 production by the 
macrophage leads to activation of T helper cells, which in turn produce interferon-gamma 
(IFN-γ) and tumor necrosis factor-alpha (TNF-α) (figure 1.2). These classical Th-1 cytokines 
stimulate the macrophages to produce reactive oxygen species (ROS) that kill the 
intracellular bacteria.  
The host responds to M.tb infection with a cell mediated immune response, aiming at growth 
inhibition of the bacteria through phagocytosis as well as cellular immunity through antigen 
presentation and recruitment of T-cells (4). The DC and macrophages are responsible for the 
binding and uptake of the pathogen. Macrophages play a fundamental role, by secreting 
cytokines and chemokines and the presentation of antigens to T-cells (5). The diagram in 
figure 1.2 shows the cytokine production by M.tb infected macrophages to activate and 
inhibit T-cell functions. 
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Figure 1.2: Schematic representation of the interaction between macrophage and T-cells in tuberculosis 
adapted from (3, 6).  
Dotted lines represent an inhibitory effect, the solid lines represents activation. 
Cell-mediated immunity is known to be vital for protection against TB disease. Following 
M.tb infection, M.tb resides mainly in the alveolar macrophages phagosome that provide the 
first line of defense, a vacuolar compartment associated with major histocompatibility 
complex (MHC) II antigen processing and presentation. MHC class II presentation of 
mycobacterial antigens by macrophages to CD4
+
 T cells is an essential part of the protective 
response against the infection.  
Phagocytosis is the internalisation of the bacteria into endosomes/phagosomes. Acidification 
of the phagosome prevents bacterial growth and increases the activities of antimicrobial 
hydrolases and directs the fusion of phagosomes with lysosomes. As a result phagosome 
acidification is a crucial event that prompts the destruction of invading pathogens (7).The 
phago-lysosome fuses with vesicles from the golgi apparatus after which antigen is 
incorporated and displayed on the cell surface by MHC-II. The antigen presenting cells 
(APC) detect the pathogen through pattern recognition receptors (8).  
In the case of M.tb the bacterium is able to inhibit the acidification of the phagosome and 
largely evades being killed by the macrophage (9). The lack of acidification in the 
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mycobacterial phagosome that is seen with M.tb infection is in part due to the absence of the 
V-ATPase on the phagosomal membrane. M.tb is speculated to be able to sense its 
engulfment by macrophages and subsequently interferes with the host signalling to promote 
its intracellular survival (7). 
1.3 T-cell functions 
 
Eradication of the M.tb infection mainly depends on the successful interaction between the 
infected macrophages and the T cells. CD4+ T cells produce IFN-γ and TNF-α after 
activation with mycobacterial antigens by APCs. CD8+ T cells, contribute as well through 
secretion of cytokines and lysing infected cells (10). CD4+ T cells are essential for the 
control of the M.tb infection. Alternatively CD8+ T-cells recognize antigens, mainly viruses, 
processed in the cytosol and presented by MHC-I molecules on their cell surface, which are 
found on the surface of most nucleated cells. CD4+ T-cells assist the host immune response 
by activating effector cells and recruiting additional immune cells to the site of disease. 
CD8+ T-cells are more likely to be cytotoxic to target cells and participate directly in the 
lysis of infected cells and induction of apoptosis of the target cells (11). CD4+ T cells are 
essential for the control of the M.tb infection. T-cells become activated upon recognition of 
mycobacterial antigens presented on the cell surface APCs. T helper type 1 CD4+ T-cells 
(Th-1) and natural killer (NK) cells secrete IFN-γ that activate macrophages to produce 
reactive oxygen and nitrogen species to assist in the killing of the M.tb bacilli. Alternatively 
CD8+ T-cells recognize antigens processed in the cytosol and presented by MHC-I molecules 
on their cell surface, which are found on the surface of most nucleated cells. CD4+ T-cells 
assist the host immune response by activating effector cells and recruiting additional immune 
cells to the site of disease. While CD8+ T-cells are more likely to be cytotoxic to target cells 
and participate directly in the lysis of infected cells and induction of apoptosis of the target 
cells (11). 
CD4+ Th-cells can be separated into different subsets, Th-1, Th-17, Treg, TFh and Th-2, 
however for the purpose of this study we focus on Th-1 and Th-2 cells. These cells derive 
from Th-0 cells, the differentiation from these precursor cells are thought to be stimulated 
through cytokines such as interleukin-12 (IL-12) (12). Phenotypically, Th-1 cells are 
characterized mainly by their ability to produce the cytokines IFN-γ and IL-2, whereas Th-2 
cells produce cytokines such as IL-4, IL-5, and IL-10. Th1-type cytokines are those that 
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activate other inflammatory and phagocytic cells capable of inhibiting the growth of 
intracellular bacteria. Th-2 cells are involved in the production of IgE and recruitment of 
eosinophils. Certain cytokines can be secreted by both Th-1 and Th-2 such as, IL-3, 
lymphotoxin, and granulocyte-macrophage-colony stimulating factor (GM-CSF) (12).  
i. IL-12p40 
 
IL-12 is a key player in host defence against M.tb, IL-12 is produced mainly by phagocytic 
cells, such as macrophages.  The phagocytosis of M.tb appears to be required for the 
secretion of IL-12 (10).  IL-12 induces the Th-1 response and down-regulates the Th-2 
response by increasing IFN-γ production from activated T cells. The IFN-γ secretion along 
with Th-1 cytokines antagonizes the IL-4 and IL-10 production (13). It has been suggested 
that IL-12 is a key cytokine in immune regulation by changing the Th-0 to the Th-1 
phenotype and can be seen as a marker of active TB disease (13). 
IL-12 acts on the T-cells, hence it serves as a link between the innate and adaptive immune 
systems (4). IL-12 naturally occurs as a heterodimer consisting of two subunits namely p40 
and p35, IL-12p40 plays a central role in the formation of granulomas, Th-1 development and 
M.tb infection control (14).  IL-12 binds to the IL-12Rβ1 and IL-12β2 complexes 
respectively which are located on the surface of the NK cells and the Th1 cells (4). Three 
cytokines produced by APCs namely IL-23, IL-18 and IL-27 have been identified to have IL-
12 like activities. The p40 subunit from IL-12 is shared with IL-23 which is coupled to a 
second chain p19, the IL-23 receptor also shares the IL-12Rβ1 subunit of the IL-12 receptor 
to form a unique receptor complex IL-23Rβ3. All three cytokines are responsible for the 
production of IFN-γ, IL-18 mainly works together with IL-12 for optimal IFN-γ production; 
IL-27 causes the proliferation of naïve T-cells and produces significant amounts of IFN-γ in 
synergy with IL-12 and IL-18 (4). It has been shown that IL-12 is vital in TB, and that the IL-
12p40 subunit plays a part in the migration of DCs from the lung to the mediastinal lymph 
nodes which are required for the activation of naïve T-cells (15). People with a congenital 
defect in IL-12p40 or in the β1 subunit of the IL-12 receptor have increased susceptibility to 
mycobacterial infection (14).  
A study was performed in a murine model to determine the importance of IL-12 within the 
context of M.tb infection (16). Administration of IL-12p70 therapy to CD4
-/-
 mice after M.tb 
infection resulted in a reduced bacterial burden in the lungs and overall survival of these 
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mice. This implicates that IL-12 is beneficial in infectious disease models that require a Th-1 
immune response in order to clear the infection. This data indicates that endogenous IL-12 is 
important for the priming of a T-cell response against M.tb infection. The addition of 
exogenous IL-12 over a period of time however did not result in a stronger T-cell response in 
the C57BL/6 mice (16). Administration of IL-12 therapy increased the expression of IFN-γ at 
an early time point, 10 days post M.tb infection, however after 1 month there was a notable 
reduction in the frequency and number of IFN-γ producing T-cells present in the lungs. This 
led to the hypothesis that the initial peak in IFN-γ production from the exogenous IL-12 may 
be the cause of the overall enhanced outcome in the CD4
-/-
 mice (16). 
Another study used an IL-12p40
-/- 
mouse model infected with M.tb to determine the 
capability of the mice to control the bacilli and determine the effects that the knock out would 
bring on the immune response (17). The study found that the absence of IL-12p40 resulted in 
the uninhibited growth of M.tb bacilli in all target organs after a systemic infection. The 
growth correlated with a reduction in the expression of mRNA of IFN-γ, this was also 
reflected in the decrease in nonspecific as well as antigen specific IFN-γ protein production. 
The lack of IFN-γ production was linked to the delay in antigen specific T-cell activation 
within the mice. The authors concluded that IL-12 plays a key role in the generation of 
antigen-specific T-cells that are able to produce IFN-γ (17). The conclusion that was drawn 
from the results was that the initial interaction of the bacilli with the host induces IFN-γ 
production. The amount of IFN-γ produced is dependent on the concentration of IL-12 and 
TNF-α within cells. An increased production of IFN-γ is necessary to induce the expression 
of IL-12Rβ2 chain on naïve T-cells. The expression of the receptor on the naïve T cells is 
needed for the T cells to act in response to the IL-12 and thus become antigen-specific IFN-γ 
producing cells (17). 
A human study found that people with genetic defects in their IL-12/IL-23/IFN-γ system, had 
increased susceptibility to mycobacteria (18). This led to the conclusion that the IL-12/IL-
23/IFN-γ system plays an important role in immunity against mycobacteria (18). 
ii. IFN-y & TNF-α 
 
With regard to M.tb infection a lot of focus has been placed on the role of IFN-γ and its 
ability to activate the macrophages to inhibit the growth of mycobacteria. It has been 
suggested that IFN-γ plays an important part in host defence and its primary role is to serve 
Stellenbosch University  http://scholar.sun.ac.za
27 
 
as a macrophage activator (3). The secretion of IL-12 by macrophages acts on the cells to 
produce IFN-γ during the initial phases of the immune response, this is essential for the 
activation and differentiation of the antigen specific Th-1cells (4). The activation of 
macrophages is dependent on IFN-γ and tumour necrosis factor-α (TNF-α) in this manner 
activating the mechanism of cell mediated immunity, to allow phagocytes to contain the 
pathogen and allow protection to the host. The host’s immune system tries to control the M.tb 
infection through activation of the CD4
+
 T-cells by IFN-γ dependant activation of 
macrophages, while IL-12 plays a role in creating and maintaining the host’s protective 
immune response (14), IL-12 is an important factor in the release of IFN-γ from the natural 
killer cells (19).  Individuals who have lower levels of IFN-γ and IL-12 have a larger risk of 
acquiring TB (4). A study done on patients with severe clinical TB who were classified 
radiographically, presented with low levels of circulating IFN-γ in peripheral blood. The low 
levels of IFN-γ are associated with a severe state of disease (20).  
IFN-γ is characteristically secreted by Th-1 cells, the higher detectable titers of IFN-γ and 
TNF-α normally observed for the duration of M.tb infection indicates that a Th-1 response is 
favoured by M.tb. This is confirmed by the nearly undetectable levels of IL-4, a Th-2 
cytokine (13).  The raised IFN-γ levels in TB patients is essential for killing intracellular 
mycobacterium through macrophage activation, as well as stimulating the release of  TNF-α 
in addition to 1, 25 dihydroxycholecalciferol (vitamin D3) (21). Both of these assist in the 
inhibition of the mycobacterium, possibly through the production of reactive oxygen and 
nitrogen species (21). TNF-α is a proinflammatory cytokine produced by monocytes, 
macrophages, and dendritic cells when it encounters M.tb or mycobacterial antigens, TNF-α 
plays a role in granuloma formation and macrophage activation. 
The interaction between NK T-cells, macrophages and T-cells is shown in figure 1.2 above. 
The production of IFN-γ from Th-1 and NK T-cells activates the macrophage which produces 
the ROS. The production of IL-12 acts as a positive feedback loop to NK T-cells. The 
production of IL-4 and IL-10 by Th-2 cells inhibits the activity of macrophages, Th-1 and NK 
T-cells but to a small extent, as IFN-γ secreted by the Th-1 cells supresses the function of Th-
2 cells (3). 
iii. IL-1 & IL-6 
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IL-1β is a proinflammatory cytokine that is involved in the host response is to M.tb. IL-1β 
similar to TNF-α, is largely produced by monocytes, macrophages, and dendritic cells. IL-1β 
is expressed in excess at the site of disease in TB patients (10).  The cytokine IL-6 has 
properties of both pro- and anti-inflammatory cytokines. IL-6 is produced at the site of 
infection at an early stage during M.tb infection. It is postulated that IL-6 may be harmful in 
M.tb infections, as it inhibits the production of TNF-α and IL-1β. However, contradicting 
reports suggests a protective role for IL-6. A study conducted on a mouse model deficient in 
IL-6, presented with an increased susceptibility to infection with M.tb, which seemed to be 
equivalent to a lack of IFN-γ production at an early stage of infection (10).  
iv. IL-10 
 
The cytokine IL-10 is produced by the macrophages following phagocytosis, however T cells 
are able to produce IL-10. IL-10 antagonizes the proinflammatory cytokine response by 
downregulating the production of IFN-γ, TNF-α and IL-12, these cytokines are essential for a 
protective immune response in a TB patient, thus it can be stated that IL-10 will obstruct the 
hosts defence mechanism to M.tb (10). Elevated IL-10 levels have been reported in patients 
with TB, the raised level of IL-10 production is associated with an increase in the disease 
prevalence. During TB an increased IL-10 production is seen more frequently in anergic 
patients, proposing that M.tb induces IL-10 production, suppressing an effective immune 
response (22).  
1.4 Glucocorticoids and TB 
 
i. Endogenous Glucocorticoids 
 
Glucocorticoids (GC) are a class of steroid hormones. In humans the main GC is cortisol and 
this hormone regulates numerous processes within the body such as, cardiovascular, 
metabolic, immunological responses and homeostatic functions (23). Cortisol in layman 
terms is often referred to as the ‘stress hormone’ as it primes the body to respond and cope in 
situations presenting with physical and emotional stress. It is also an essential regulator of 
inflammatory processes and immune functions; cortisol plays a key role in several processes 
associated with host defence mechanisms (24). In PBMCs of TB patients it was reported that 
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the mRNA of the human glucocorticoid receptor (hGR), consisting of the two isoforms hGRα 
and hGRβ ratio was higher than those in the control group (25).Upon analysing the ratios 
against the disease severity, the severe TB cases showed the lowest mRNA hGRα/β ratio. 
The findings in the severe cases are compatible with a certain degree of GC resistance, which 
could potentially explain the increased inflammation and tissue destruction that occurs in 
these patients (25). 
ii. Control of secretion of Glucocorticoids 
 
Cortisol is synthesized from cholesterol in the zona fasciculata cells of the adrenal cortex 
(23). The release of the hormone follows a distinct circadian rhythm, with maximum levels 
reached just prior to waking up, levels decrease throughout the day with lowest levels 
reached in the early phase of sleep (23). In a situation posing a threat of emotional and/or 
physical trauma cortisol is released. The extend of the stress response is dependent on 
different factors regarding the stress stimulus such as the nature, duration, intensity and the 
person’s previous experience of the stimulus (23). 
The hypothalamus pituitary axis (HPA) is responsible for the secretion of GCs for both the 
stress response and the normal circadian rhythm (figure 1.3). The hypothalamus acts as a 
sensor of changes in the external and internal environment. It receives screens and combines 
neural and humoral information from different sources. The hypothalamus responds to the 
received stimuli, circadian factors and either physical or emotional, through activation of a 
signalling cascade leading to glucocorticoid synthesis (24). 
The first step is the release of a hypothalamic neurohormone, corticotrophin-releasing 
hormone (CRH) from parvocellular neurones. CRH moves from the hypothalamus through 
the hypophyseal–portal blood vessels to the anterior pituitary gland where it stimulates the 
release of adrenocorticotrophic hormone (ACTH) from the corticotrophs.  ACTH acts on the 
adrenal cortex via type 2 melanocortin receptors to start the synthesis of cortisol, once 
synthesised it is released into the systemic circulation. Negative feedback ensures the 
sensitivity of the HPA axis to incoming stimuli. The glucocorticoids use the negative 
feedback loop to ensure that the secretion of CRH and ACTH from the hypothalamus and 
anterior pituitary gland respectively is suppressed (24).  
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It has previously been shown that a decrease in dehydroepiandrosterone (DHEA) levels is 
accompanied by an increase in the cortisol/DHEA ratio in individuals with active TB (26). 
DHEA is a circulating steroid hormone, produced by the adrenal glands, the gonads, and the 
brain, where it functions predominantly as a metabolic intermediate in the biosynthesis of the 
sex steroid hormones, androgen and estrogen. The increase in GCs exerts anti-inflammatory 
properties that oppose protective immune responses against intracellular pathogens. The 
decrease in DHEA in TB patients can account for the inhibitory effect of GCs on the immune 
response, although it does not account for the control of inflammatory processes. Thus the 
increases in cortisol levels are insufficient to correct for the loss of anti-inflammatory 
responses due to the reduction of DHEA in TB patients (26).  
 
Figure 1.3: Diagram showing the HPA axis and the feedback loop responsible for the release of cortisol 
adapted from (18). 
 
1.5 Mechanism of action 
1.5.1 Hormone signalling 
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Glucocorticoids act largely through a nuclear receptor called the glucocorticoid receptor 
(GR). The mechanisms of action can either occur through genomic mechanisms that involve 
the nuclear receptors, or the non-genomic mechanism which acts through the classical 
receptors or membrane associated receptors and signalling cascades. 
i. Genomic mechanisms of action 
 
If there are no ligands present the GR resides within the cytoplasm bound to various 
chaperone molecules composed of heat shock proteins and immunophilins, forming a large 
multi-protein complex (27). Upon interaction between the ligand and GR, the receptor 
dissociates from the heat shock proteins leading to nuclear translocation of the active 
receptor-ligand complex. Once in the nucleus the GR controls the transcriptional activity of 
the GC responsive genes by binding to the GR response element (GRE) or the negative GRE 
(nGRE) in the promoter regions of target genes (28). The transcriptional regulation by the GR 
is exerted through the classical transcriptional activity on GC responsive promoters through 
the binding of a homodimer ligand-receptor complex to the GREs (29). In the trans-
repression hypothesis, ligand-activated GR interacts with, or tethers to, key transcription 
factors, such as NF-kB, AP–1 and STAT, to switch off inflammatory gene transcription such 
as IL-1 and IL-6 (30)(29). The transcription factors are involved in regulating the expression 
of pro-inflammatory genes therefore binding to these transcription factors results in the trans-
repression of cytokine secretion such as, IFN-γ, TNF-α, IL-1 and IL-2 involved in the host 
inflammatory responses (31). The mechanisms describes above indicates various mechanisms 
of GC repression could either be independent of the requirement for a gene expression 
(classical trans-repression) or dependent on gene expression (repression through the trans-
activation of anti-inflammatory genes). The GRE facilitated trans-activation of transcription 
is important for the up-regulation of several genes which are involved in the regulation of 
immune functions. The ligand-receptor complex can bring about transcription, upon binding 
to the GREs, for instance IκB, annexin-1, mitogen-activated protein kinase (MAPK) and IL-
10 (28).Changes induced by genomic mechanisms usually take hours or days. However, 
some anti-inflammatory and immunosuppressive effects of GCs occur rapidly thus non-
genomic effects have been suggested as an explanation. A schematic representation of the 
genomic signalling can be seen in figure 1.3. 
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ii. Non-genomic mechanism of action 
 
Non-genomic GC signalling mechanisms (figure 1.3) work independently of their effects on 
transcriptional regulation promoted inside the nucleus, but utilize other pathways of action 
(32). Such actions of GCs are rapid and take place within seconds to minutes after initiation 
in contrast to genomic actions that usually require many hours. Three alternative non-
genomic GC mechanisms have been suggested: Firstly, signalling through a membrane GR 
(mGR). Secondly, direct membrane effect of the GCs and lastly, molecules released from 
GR-hsp-complex are said to mediate rapid effects (32). 
Direct membrane effects of glucocorticoids have been observed at high doses of GCs in red 
blood cells, leukocytes, a number of cancer cell lines and certain neuronal cells. The non-
genomic effects of GCs have been described in different cellular processes for example, actin 
structures, neuronal membranes, transmembrane currents, intracellular Ca
2+
 mobilization and 
signal transduction pathways. Very high concentrations of GCs seem to change cell 
membrane fluidity and other physico-chemical properties through insertion in the lipid 
bilayer of cell membranes (32). The inhibition of Lck and Fyn in CD4+ lymphocytes serves 
as an example of GR-mediated modulation of the activity of signalling molecules that are 
connected to the plasma membrane. By blocking the recruitment of Lck and Fyn to the T-cell 
receptor (TCR), affecting the stimulation of downstream kinases MAPK, JNK, and protein 
kinase B and C and so inactivating the TCR signalling (28,33).The GR also translocates into 
the mitochondria and regulates their activities possibly in a non-genomic fashion. The way in 
which the GR-mediated apoptosis in the mitochondria works is not well understood. 
However, the reduction of the membrane potential of the mitochondria, the interaction with 
pro-apoptotic B-cell lymphoma 2 (Bcl-2) family proteins, and the stimulation of the Bcl-2–
associated X protein (Bax) / Bcl-2 homologous antagonist (Bak) assembly may play a role. 
Additionally, the GR could influence the induction of apoptosis by directly changing the 
transcription of the mitochondrial genes through interaction with their GRE-like sequences 
(32). 
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Figure 1.4: Diagram shows the genomic and non-genomic mechanism of action of GCs (28). 
 
1.5.2 GR and TCR interaction 
 
It has been reported that in human T-cells (figure 1.4) the GR is linked to the early signalling 
complex of lymphocyte-specific protein tyrosine kinase (Lck) and the proto-oncogene 
tyrosine protein kinase (Fyn) molecules of the TCR after TCR stimulation (32). 
The activation of T-cells occurs in response to the presentation of antigen. Stimulation of the 
TCR is triggered by MHC II molecules on APCs that present antigen peptides to TCR 
complexes, leading to the activation of the TCR complex. This happens through the 
activation of Lck and Fyn which results in TCR phosphorylation of the tyrosine residues (33). 
The kinases Lck and Fyn are essential for TCR signalling, Lck binds to CD4 or CD8 co-
receptor and Fyn has been known to bind to CD3 cells. Upon the initiation of the T-cell 
signalling cascade through the activation of Lck, ζ-associated protein 70 tyrosine kinase 
(ZAP-70) is recruited to the TCR complex where it is phosphorylated and activated by Lck. 
Once activated ZAP- 70 in turn phosphorylates linker for activation of T-cells (LAT) which 
activates the downstream signalling cascades that includes protein kinase C (PKC), protein 
kinase B (PKB) and MAPKs such as p38 MAPK, extracellular-signal-regulated kinase (ERK) 
and JNK (33). ERK (Extracellular signal-Related Kinase) is a family of two, homologous 
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proteins known as Erk1 (p44, MAPK3) and Erk2 (p42, MAPK1) both of them function in the 
same signalling pathway. The two proteins are often collectively referred to as ERK1/2 or 
p44/p42 MAP kinase. The activation of ERK-1 and ERK-2 is mediated by MEK. Upon 
activation ERK MAP kinase 1/2 can induce a wide range of cellular processes, proliferation, 
differentiation and transcription. Once ERK 1/2 is activated it translocates to the nucleus 
where it phosphorylates its nuclear targets. The ERK pathway is considered the classical 
MAPK (Mitogen-Activated Protein Kinase) signalling pathway (34). This signalling pathway 
controls and regulates the growth and survival through the promotion of cell proliferation and 
the prevention of apoptosis. ERK is activated by growth factor stimulation of receptor 
tyrosine kinases (RTKs), this leads to the activation of the Ras-Raf-MEK,-ERK pathway that 
results in MEK, and the phosphorylation and activation of ERK1/2 (p44/044) on the 
threonine-x-tyrosine (TxY) motif (Thr185/Tyr187 for Erk1 and Erk2, respectively). The 
transcription factor cAMP response element-binding protein (CREB) binds to DNA 
sequences called cAMP response elements (CRE) to increase or decrease the transcription of 
downstream genes. Once activated the CREB protein binds to a CRE region, it is then bound 
by a CBP which then co-activates CREB to turn gene expression on or off.  
An example of non-genomic GR-mediated modulation linked with the plasma membrane is 
the inhibition of Lck and Fyn in T-cells, preventing the recruitment of Lck and Fyn to the 
TCR, thus preventing downstream TCR-mediated signaling events, such as the stimulation of 
downstream kinases MAPK and JNK (33). The properties of GC-induced rapid effects on 
signal transduction in T-cells were investigated (33). It was reported that there was clear 
differences in the phosphorylation patterns between the dexamethasone (DEX) treated and 
non-DEX-treated cells. This led to the conclusion that there are rapid DEX dependant effects 
within the signal transduction. The largest observed effect was the decrease in 
phosphorylation of Lck/Fyn kinases in the DEX treated group, as well as an impairment of 
recruitment of these substrates to the TCR complex. Thus impairing the recruitment of 
Lck/Fyn disrupts the formation of the GR-TCR-Lck-Fyn multi-molecular complex, 
suggesting that Lck and Fyn play a key role in TCR activation. Lck and Fyn act as rapid 
molecular targets of GC action in activated human T-cells through a GR dependant 
mechanism (33). GCs can also obstruct TCR signaling further downstream at the level of 
1,4,5-triphosphate (IP3) assisted release of Ca
2+
 from the endoplasmic reticulum. Calcium 
responses were proposed to be mediated to some extent by a protein-protein interaction 
between Lck and IP3 receptor (35). A knock down of Lck led to a loss of Lck expression and 
activity and resulted in IP3 receptor down-regulation. T cells stimulated with DEX showed 
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rapid conversion in calcium signalling induced by GC stimulation. The authors concluded 
that the GC mediated inhibition of Lck controls the pattern of TCR responses by negatively 
regulating IP3 receptor expression (35).  
 
Figure 1.5: Diagram shows the suppressed immune signalling through TCR as a result of GC treatment 
(28).  
1.5.2.1. Signalling molecules not specific to TCR signalling 
 
Signalling through the TCR signalling pathway is not the only way in which cells can react to 
a change within their environment; cells can act in many different ways through a selection of 
intracellular signalling pathways. Some signalling molecules will signal through the Receptor 
Tyrosine kinases (RTK) pathways. The activation of the Signal Transducers and Activators 
of Transcription (STAT) proteins, STAT5A and STAT5B are activated through tyrosine 
phosphorylation usually via JAK proteins. The two proteins are often collectively referred to 
as STAT5A/B. STAT5A/B plays a key role in immune cell development and regulation, and 
facilitates IL-2 and IL-15 signalling in regulatory T-cells. The p70S6 kinase acts downstream 
of PIP3 in the PI3 kinase pathway. The kinase p70S6 targets the substrate in the S6 ribosomal 
protein, the phosphorylation of S6 leads to protein synthesis at the ribosome.  The activation 
of mTOR leads to the phosphorylation of p70S6 therefore leading to its activation. The 
STAT3 protein is activated through the phosphorylation of the tyrosine, in response to 
various cytokines and growth factors. STAT3 facilitates the expression of a variety of genes 
in response to cell stimuli and therefore plays an important role in many cellular processes 
such as cell growth and apoptosis. The p38 MAP kinase (further just referred to as p38) 
forms part of the MAP kinases that respond to stress stimuli, such as inflammatory cytokines, 
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heat shock or osmotic shock. The functions of p38 include the involvement in cell 
differentiation, apoptosis and autophagy. MKK3 and SEK are responsible for the activation 
of p38 by the phosphorylation at threonine and tyrosine residues. Activated p38 can 
phosphorylate transcription factors such as ATF2, Mac and MEF2, p38 can also 
phosphorylate post-transcriptional regulating factors such as TTP. The activation of JNK 
occurs through dual-phosphorylation of threonine and tyrosine residues within a Thr-Pro-Tyr 
motif. JNK alters the activity of various proteins that located at the mitochondria or acts in 
the nucleus. JNK activates downstream molecules such as, c-Jun, ATF2, ELK1, p53 and 
HSF1. The downstream molecules that are inhibited by JNK activation include NFAT4, 
NFATC1 and STAT3. Through the activation and inhibition of molecules JNK regulates 
cellular functions including cell growth, differentiation, survival and apoptosis. IκBα is part 
of a group of cellular proteins that function to inhibit the transcription factor NF-κB. IκBα 
inhibits NF-κB by hiding the nuclear localization signals of the NF-κB proteins and ensuring 
they remain in an inactive state within the cytoplasm. IκBα blocks the capacity of the 
transcription factor NF-κB to translocate to the nucleus.  
 
1.5.3 Progesterone 
 
Progesterone is a steroid hormone that is involved in the female menstrual cycle, pregnancy 
and embryogenesis. Progesterone is produced by the corpus luteum, the adrenal glands and 
the placenta during pregnancy. Progesterone exerts its primary action through the 
intracellular PR, although the presence of membrane bound progesterone receptor has been 
suggested. The progesterone receptor (PR) is a protein found inside cells, and is activated by 
the steroid hormone progesterone. The effects of progesterone are mediated by two 
functionally different isoforms of the progesterone receptor, PR-A and PR-B.  Progesterone 
bound PR-A and PR-B have different transcription activating properties. The PR-B functions 
as a transcriptional activator in most cell and promoter environments, whereas PR-A is 
transcriptionally inactive and functions as a strong ligand dependent trans-dominant repressor 
of steroid hormone receptor transcriptional activity. An inhibitory domain, which maps to the 
amino terminus of the receptor, exists within both PR isoforms. The PR has three known 
membrane receptors, mPR-α, mPR-β and mPR-γ, the membrane PR’s are thought to assist 
with the signalling of progesterone (36). The signalling through membrane bound receptors 
are more rapid than the genomic method of the classic steroid receptors. The androgen 
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receptor (AR) is a type of nuclear receptor that is activated by binding of either of the 
androgenic hormones testosterone or dihydrotestosterone in the cytoplasm, where upon they 
then translocate to the nucleus. The AR is closely related to the PR. The progesterone 
receptor membrane component 1 is involved in the heme binding as well as binding and 
activating p450 proteins, which play a key role in drug, hormone and lipid metabolism (36).  
 
A recent study hypothesized that intracellular PR plays a role in regulating the CD4+ T cell 
activity and adaptive immune responses in vivo (37). A mouse model was used where the use 
of the intracellular PR had been knocked out. They found that the knock of the intracellular 
PR suppressed the T-cell dependant antibody responses. It was speculated that the 
suppression occurred largely by reducing CD4+ effector T cells activity, potentially through 
the transcriptional repression of the IFN-γ (37). There is increasing evidence that 
progesterone modulates immune functions in mammals (38), such as the changes in the 
symptoms of autoimmune diseases for example rheumatoid arthritis. In women changes in 
the cellular immune response to infection and the expression of IFN related genes have been 
observed during the menstrual cycle and pregnancy. Dosiou et al. suggested that the observed 
increase in membrane progesterone receptor alpha (mPR-α) expression could potentially 
contribute to the immune modulation of progesterone during the second half of the 
menstruation cycle and during pregnancy (39). When T cell clones that have a known Th-1 
cytokine profile were stimulated with CD3 and progesterone, detectable amounts of IL-4 
mRNA was found as well as the expression of CD30 on their surface membrane (40). These 
results show that progesterone can support the development of Th cells producing Th-2 
cytokines (40). Progesterone promotes differentiation of Th-2 cells and production of type 2 
cytokines like IL-10. Nonetheless, most studies fail to detect the presence of the nuclear 
progesterone receptor (nPR) in immune cells, this led to the suggestion that there must be 
alternative mechanisms of action for progesterone (figure 1.5) (38). 
mPRs are suggested as alternative progesterone receptors, another group of proteins proposed 
to mediate non-genomic signalling. The different forms alpha, beta, and gamma were first 
identified in fish. They play a role in oocyte maturation and contribute to the pathogenesis of 
epithelial ovarian tumors as it is differentially expressed in ovarian carcinoma (41). The 
expression of mPR-α in human breast cancer cells was reported to decrease cAMP levels 
after progesterone stimulation by activating the MAPK pathway (42). In agreement, 
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expression of the seatrout mPR-α in human breast cancer cells was shown to rapidly activate 
the MAPK (ERK1/2) signalling cascade and lower intracellular cAMP levels in response to 
progesterone (43). These findings are contradicting to the findings that describe that cAMP 
concentrations in isolated plasma membrane preparations from breast cancer cells who stably 
express human mPR-α were down-regulated upon treatment with progesterone (44). 
Contradicting results are seen in the function of mPRs in relaying MAPK activation in 
response to progesterone. The mPR-α from seatrout and zebrafish were reported to activate 
ERK1/2 when expressed in breast cancer cells (43). However, the human mPRs appear to not 
signal through ERK1/2 but activate p38 MAPK. Though, this speculation was only based on 
the observation that treatment of cultured human myometrial cells with cell-impermeable 
progesterone-BSA led to rapid phosphorylation of p38, but not ERK1/2 (45). 
 
In peripheral blood leukocytes and T lymphocytes from women of reproductive age and in 
the Jurkat cell line, the transcripts of membrane progesterone receptor (mPR)-α and mPR-β 
have been identified (38). A study done using flow cytometry reported that the mPR-α 
protein is localized on the cell membrane and the N-terminus is situated extracellularly (46). 
It further reported that the expression of the mPR-α appeared to be hormonally regulated in 
the CD8
+
 T cells, but this was not observed in the CD4
+
 T cells. During the state of high 
progesterone levels, in the mid-luteal phase, there was an increase in mPR-α expression on 
the CD8
+
 T cells. The expression of mPR-β does not change in either the CD8
+
 or the CD4
+
 T 
cells between the follicular and mid-luteal phase. This led to the hypothesis that the increase 
in the expression of mPR-α in the CD8+ T cells during the luteal phase could be a 
contributing factor for the immune modulatory effect of progesterone in the second half of 
the menstrual cycle and during pregnancy (46).  
Progesterone receptor membrane component (PGRMC1) has been proposed as alternative to 
progesterone receptor, this protein is expressed in various human tissues including heart, liver 
and placenta (45). PGRMC1 is strongly expressed in different kinds of cancer including lung, 
breast and ovarian cancer and is discussed to promote cell survival and insensitivity to 
chemotherapy (47). It has been shown that progestins are capable of activating a variety of 
signalling pathways through mPR-α and progesterone membrane component 1 (PGMRC1) 
(38). In human myometrial cells upon progestin binding to the mPR-α, leads to the activation 
of the p38 MAPK, which leads to the phosphorylation of myosin light chain protein in these 
cells. Activation of a pertussis toxin sensitive pathway via mPR-α and mPR-β in human 
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myometrial cells alters the nPR transactivation activity, by activating this pathway it also 
alters the expression of nuclear steroid receptor coactivator (SRC-2). There have been 
indications that progestins initiate Ca
2+
 mobilization from intracellular stores through both 
mPR-α and PGMRC1 (38). However there are studies that contradict these findings, another 
study failed to verify that mPRs are expressed on the cell surface or that they mediate 
progesterone dependant signalling events, for example activation of p38 MAPKs, Ca
2+
 
mobilization or the inhibition of cAMP production (36). 
 
 
 
Figure 1.6: Schematic overview of the proposed signalling mechanism of the non-genomic progesterone 
actions mediated by the classical or nuclear PR. Alternatively signals through the non-classical putative 
progesterone receptors, PGRMC1 and the mPRs (48). 
 
1.5.4 Injectable progestins 
 
Worldwide there are roughly 150 million women at present who use hormonal contraceptives 
(49). Of these ≥ 100 million women use combination oral contraceptive pills and ≥ 50 million 
women are using synthetic progestin injectables, predominantly medroxyprogesterone acetate 
(MPA), MPA is used mainly in developing countries (49)(50)(46). MPA is a synthetic 
progestin used by woman as a hormonal contraceptive that is injected intramuscularly every 3 
months. MPA is favoured amongst women as it requires fewer clinic visits throughout the 
course of the year, and is administered in local clinics to women free of charge. 
Norethisterone enanthate (NET) is the two month injectable contraceptive that is available at 
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clinics, but is used less frequently as contraception of choice amongst woman. However for 
women who suffer from TB and are receiving Rifampicin as part of their course of TB 
treatment, MPA and NET, which are progestin only contraceptives and the recommended 
choice during the course of TB treatment. An estradiol containing form of hormonal 
contraception is not recommended. This is due to it being rapidly metabolized as a result of 
the up-regulation of p450 cytochromes by Rifampicin during the course of the treatment and 
therefore ineffective as a form of contraception (51).  
1.5.5 Molecular mechanisms of action of synthetic progestins 
 
MPA can bind to both the glucocorticoid receptor (GR) and the progesterone receptor (PR) 
respectively (52). Both MPA and NET have been shown to bind to the androgen receptor 
(AR) and mineralocorticoid receptor (MR) (53). From a structural point of view MPA, a 17α-
hydroxyprogesterone derivative is more comparable to progesterone than to NET which is a 
19-nortesterone derivative (54). 
 
Figure 1.7: Depicts the chemical structure of the following hormones. (a) Progesterone, (b) MPA and (c) 
NET (54). 
MPA in itself is the main progestogenic compound, rather than its metabolites, although in 
the case of NET, NET-A and NET-EN are hydrolysed to NET and its metabolites which 
together have progestogenic action. It has been reported that NET metabolites appear to have 
more non-progestogenic actions than MPA metabolites (54). MPA shows a higher binding 
affinity to the GR, and MPA mimics GC activity by repressing cytokine genes in vitro. MPA 
is very effective as a GR agonist, greater than both progesterone and NET, for both 
transrepression and transactivation (54). The agnostic properties of the hormones are 
reported, according to their trans-activation and trans-repression potency and efficacies (55). 
Upon the binding of the receptor homodimer to the GREs an increase in gene transcription 
occurs, known as trans-activation. A monomeric ligand-receptor complex changes gene 
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expression through the process of protein to protein interactions with transcription factors 
which is referred to as trans-repression (27). The following parameters were to classify the 
hormones; ≥ 85% efficacy as a full agonist; < 85% efficacy as a partial agonist when 
compared to the synthetic GC, DEX. The hormones where classified as follows; cortisol – 
full agonist; MPA – full agonist or partial agonist; Prog – partial agonist and NET – 
antagonist. The hormone was deemed an antagonist when it showed no activity on any of the 
three promoters (55). 
Kontula et al. experimentally determined the binding affinity of certain steroid hormones to 
the GR and PR. They found that biologically active progestins that contain a pregnane 
structure (progesterone and MPA) can bind to both receptor groups, while steroids like DEX 
only have a binding affinity for the GR. However MPA has a much higher binding affinity to 
the GR than the PR (52). Within the experimental study conducted by Kontula et al. it was 
shown that progesterone decreases the lymphocyte functions such as antigen presentation, 
cytokine production and pathogen elimination. While under the same stimulatory conditions 
MPA showing a higher affinity for the GR, produced a different response pattern, similar to 
the effects seen by DEX (52). It was found that progesterone showed a general suppressive 
activity on the lymphocyte function when experimentally tested with mitogens for activating 
T cells, T and B cells or B cells only. Whereas MPA displayed an affinity for the GR, 
however when stimulated with T cell mitogens lymphocytes become more sensitive to 
inhibitory activity. While the inhibitory activity of the B and T cell mitogens was suppressed 
to a lesser degree than the lymphocytes response to the B cell mitogen only (52).  
MPA and NET can bind to the GR, PR, AR and the MR. Table 1.1 is a summary from a 
recent review article published in Steroids by Africander et al (56). The table shows the 
relative binding affinities (RBA) of progesterone and the synthetic progestins to steroid 
receptors. The RBA shown here were determined by recombinant human steroid receptor 
binding in vitro in a study performed by Philibert et al. The biological activity listed below 
was determined in preclinical models by different study groups. 
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Table 1.1: Relative Binding Affinities (RBA) to steroid receptors, and biological activity of 
progesterone and synthetic progestins. 
 
   
- RBAs are shown as a percentage of total specific binding with that of the natural ligand.  
Symbols of biological activity (-) not effective; (+) effective; (++) strongly effective; (±) literature inconsistent. 
a) Determined by recombinant human steroid receptor binding in vitro. b) Means of RBA determination not 
defined. c) RBAs were determined by overexpressing the hGR in COS-1 cell line. d&e) Rat uterine cytosols 
were used to determine RBAs for the PR and estrogen receptor (ER), rat prostate and rat thymus cytosols were 
used to measure RBAs for the AR and GR respectively. RBAs for the MR were determined by overexpressing 
the hMR in COS-1 cells. f) RBAs were determined by overexpressing the hAR and hMR in COS-1 cells. g)  
RBA was determined by overexpressing the hAR in COS-1cells. 
From the above table it can be seen that the binding affinity for the PR is highest for MPA 
followed by NET and lastly progesterone. Both the synthetic progestins exhibit strong 
effective progestogenic activity. Although they are made to act like their natural occurring 
ligand progesterone, the possibility remains that they could act differently as a result of their 
affinities for different steroid receptors (56). 
The AR is found within many different tissues for example, vaginal tissues, testes, mammary 
glands, prostate and muscle (57).  The AR plays a key role in normal ovary and breast 
development in females, and male reproductive functions. Bamberger et al. found that the 
lymphocytes expressed AR at mRNA levels, but the AR protein expression was found to be 
below the detection limit of Western blot experiments (58). From table 1.1 it can be seen that 
MPA and NET bind to the AR with relatively high binding affinities, and display androgenic 
effects in the rat model. This could put forward the notion that the androgenic effects are AR 
mediated (56) .  
The MR is found within the epithelial tissues of the kidneys and the colon, can also be found 
in the heart and adipocytes. It has been reported that MR on myeloid cells are necessary for 
efficient classical macrophage activation by pro-inflammatory cytokines (59). Macrophages 
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from mice lacking MR in myeloid cells exhibited a transcription profile of alternative 
activation. In vitro studies showed that MR deficiency corresponded with inducers of 
alternatively activated macrophages (for example, IL-4 and agonists of PPARγ and the GR) 
to enhance alternative activation. In vivo the MR deficiency in macrophages mimicked the 
effects of MR antagonists (59). Aldosterone is the natural ligand for MR, known to regulate 
blood pressure through sodium and water retention systems in the kidney (57). Progesterone 
acts as an effective MR antagonist, this is not reflected upon binding of MPA and NET to the 
MR. They have a fairly low binding affinity and do not exhibit any agonist or antagonist 
properties at the MR (54).  
1.5.6 MPA and infectious diseases 
 
Numerous studies have indicated that the use of hormonal contraceptives can increase 
susceptibility to HIV infection. A 10 year cohort study conducted in Kenya amongst women 
sex workers showed that women using MPA or oral contraceptives had a higher risk of 
acquiring HIV-1 than non-contraception users (50). Another study conducted amongst 
African women that were MPA users, showed that they had higher seroprevalence for HIV-1 
and roughly 6% of the HIV risk was due to MPA use (50). 
A study done on 342 adolescent girls aged 14-17years in the United States, found no 
association between MPA use and an increased risk in an acquiring an sexually transmitted 
infection (STI) (60). The cohort displayed equal risk of acquisition of a STI between non-
users and MPA users alike. This finding was contradictory to a study done among an adult 
women cohort, here MPA use and STI infection a significant association was found (61). 
A recent study looked at the possible mechanism through which MPA could affect the 
acquisition of HIV-1 (62). MPA suppressed the proliferation of T-cells after antigen 
presentation, and reduced the ability of the plasmacytoid dendritic cells to respond to 
stimulation. Additionally, MPA prevented the down-regulation of HIV co-receptors CCR5 
and CXCR4 on activated T-cells, and increased the rate of HIV-1 replication in PBMCs. 
These mechanisms can stimulate HIV-1 proliferation in the genital tissues in the early stages 
of infection, and add to the increased shedding of HIV-1 in the genital tract of infected 
women (62). The HIV-1 virus accessory protein, viral protein R (Vpr), can modulate the 
transcriptional response of the GR. GCs and Vpr have been reported to induce apoptosis in 
various cells, including T-cells (63). They have previously shown that the injectable 
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contraceptive, MPA is a partial to full agonist for the GR, unlike NET. They found that the C-
terminal part of the Vpr peptide, or HIV-1 pseudovirus, along with stimulation with DEX or 
MPA amplified the apoptotic phenotype, unlike NET and progesterone. They conclude that 
contraceptive doses of MPA but not NET or physiological doses of progesterone could 
potentially accelerate depletion of CD4+ T-cells in a GR-dependent manner in HIV-1 
positive women, thus adding to immunodeficiency seen within the women. This suggests that 
careful must be made in the choice of progestin used in contraception may be critical to 
susceptibility and progression of diseases such as HIV-1 (63). 
 
Animal studies have been conducted to look at the effect that progesterone has on viral STI 
susceptibility. Sodora et al reported that Rhesus macaques were more susceptible to 
intravaginal simian immunodeficiency virus (SIV) infection during the high progesterone 
luteal phase compared to the high estrogen phase of the follicular phase. Administrating MPA 
to the Rhesus macaque monkeys had a 7-fold increase in the acquirement of SIV, 
accompanied by a significant increase in viral shedding during acute phase (64). Studies have 
also been performed in murine models, where they found that under the influence of 
progesterone the mice became more susceptible to sexually transmitted bacterial and viral 
infections. The treatment of the mice with MPA increased their susceptibility to genital HSV-
2 infections by a 100-fold compared to the 10-fold increase seen with progesterone (65). 
However, there are some contradicting findings, recently it was found that MPA did not 
eliminate the control of viral replication but might have enhanced viral control after IV 
challenge in simian human immunodeficiency virus (SHIV)-immunized rhesus macaques 
(66). MPA was reported to stimulate T cell activation and T regulatory responses prior and 
just after SIV challenge. This led to the conclusion that the observed decrease in protection in 
vaginal SIV challenge in MPA treated SHIV immunized animals can be attributed to the 
changes in genital tract such as thinning of vaginal epithelium that enhance transmission (66). 
A recent study done on woman, who received MPA as part of their injectable contraceptive 
regime, revealed that the production of IL-12, IL-1α, IL-10 and IL-13 was inhibited in these 
women (67). It was speculated that the decrease in cytokine secretion could be ascribed to the 
lower levels of circulating monocytes within these women using MPA. This led to the 
conclusion that the lower levels of monocytes in circulation accompanied by the inhibition of 
IL-1 and IL-12 production, could lead to an increased risk of TB infection as a result of an 
increased susceptibility to TB (67). 
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Problem Identification 
 
MPA is currently the leading choice of hormonal contraceptive amongst the women in low 
socio economic classes, as it is provided free of charge at South African health care clinics 
and only requires 4 clinic visits during the course of a year.  Female MPA contraceptive 
users, that are TB household contacts have shown to respond differently to antigens of 
mycobacterial origin than control individuals as found through previous studies conducted 
(67). It has been found that the MPA contraceptive users produced significantly lower levels 
of IL-12p40, TGF-alpha, IL-13, IL-1alpha, sCD40L when analysed in a 3 day PBMC 
stimulation assay (67). The women using MPA showed a decrease in the amount of 
circulating monocytes potentially attributed to GC activity of this contraceptive. The 
suppression of cytokines and reduced monocyte count could add to the susceptibility of MPA 
users (67).  
My study wishes to show the immune modulatory mechanisms underlying the observed 
cytokine inhibition that was seen in the MPA users studied previously. My study will be 
looking at the signalling pathways that are involved in the presence of anti-CD3 and BCG 
stimulation, and the influence that the presence of the hormones will have on the activation of 
the signalling molecules.  
Rationale 
 
In my study the effect of the hormones cortisol, progesterone, MPA and NET on the secretion 
of cytokines and phosphorylation of signalling molecules was determined after stimulation 
with BCG and CD3 respectively. PBMCs were stimulated with BCG to induce an antigen 
specific response, which occurs through recognition of the antigen bound to MHC on antigen 
presenting cells by the T-cell receptor (TCR) complex. This form of stimulation also leads to 
co-receptor activation and activation of more complex signal transduction cascade besides 
TCR signalling. Leading to cellular responses aimed at eliminating the encountered 
pathogens. Antigen presentation forms part of the acquired immune system. Whereas CD3 
stimulation induces a non-specific response, which only leads to TCR activation and 
signalling without co-receptor activation. The cells of the innate immune system recognize 
and react to encountered pathogens in a non-specific way, by recruiting immune cells to sites 
of infection through the production of cytokines. 
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Hypothesis  
 
I hypothesise that due to its selective GC activity MPA but not NET modulates BCG and 
anti-CD3 induced cytokine responses and signalling pathways in human PBMCs. 
Aim  
  
The aim of the study is to compare the underlying immune modulatory properties of MPA 
and NET and compare them to the endogenous hormones cortisol and progesterone. I will 
investigate whether MPA and/or NET affect BCG and anti-CD3 induced cytokine expression 
and activation of signalling molecules in human PBMCs. 
Research Objectives 
 
1. To determine the effect of cortisol, MPA, progesterone and NET on the BCG and 
anti-CD3 induced cytokine secretion in human PBMCs.  
2. To determine the presence of GR and PR protein in human PBMCs through Western 
blot. 
3. To determine the mRNA of GR, PR, AR, mPR-α, mPR-β, mPR-γ and PGRMC1 in 
human PBMCs, as well as the effect that the addition of cortisol, MPA, progesterone 
and NET on the receptor mRNA levels. 
4. To determine whether after BCG and anti-CD3 induced activation of signalling 
pathway is altered by cortisol, MPA, progesterone and NET.  
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Research Plan 
 
The schematic diagram below depicts the research plan set out to achieve our aims. 
 
Figure 1.8: A diagram of the proposed research plan to meet the research aims for the study. 
  
Stellenbosch University  http://scholar.sun.ac.za
48 
 
Chapter 2: Materials and Methods 
2.1 Cell Culture 
2.1.1 Peripheral Blood Mononuclear Cells (PBMCs) 
2.1.1.1. Study Participants 
 
Participants were chosen on the following criteria: women who are non-contraceptive users 
and have a positive Tuberculin Skin Test (TST). Blood was collected from these women 
throughout the duration of the project. To be eligible for study participation the women had to 
be between 15 and 45 years of age. They were not using contraceptives or receiving any form 
of steroid treatment, not pregnant and had not been sterilized.  
2.1.1.2 PBMC Isolation 
 
PBMCs were isolated from 40ml whole blood collected from each of the participants for 
every time point, following the protocol implemented in our laboratory. Ethical clearance for 
the sample processing and PBMC isolation was granted to the SUN-Immunology Research 
Group (SUN-IRG) under the ethics number: N05/11/187. The ethical clearance was awarded 
to the project entitled ‘Biomarkers of protective immunity and surrogate markers of TB 
disease in Africa – Gates Grand Challenge project 6-74.’ The ethically approved protocols 
for the GC6-74 project for PBMC isolation was used for the duration of this project.  
The protocol followed is explained here in brief. Whole blood sample collected was diluted 
in a ratio of 1:1 in sterile phosphate buffered saline (PBS) (Lonza. Basel, Switzerland), and 
layered on 15ml Histopague (Sigma-aldrich. South Africa). The blood was centrifuged at a 
low speed, 1500rpm, to allow for density gradient separation. The buffy coat containing the 
white blood cells was harvested into a 50ml conical tube (Becton Dickenson. New Jersey, 
USA) with 40ml PBS and centrifuged for 10minutes at 1500rpm, the cell pellet was re-
suspended in 10ml PBS, that serves as the final wash step. The cell pellet obtained at the end 
of the last wash step was re-suspended in 1ml pre-warmed AIM-V media (Invitrogen, Life 
Technologies. California, USA), a 1:4 dilution is made with cells and trypan blue dye 
(Sigma-Aldrich) and 10μl of diluted cells was loaded onto a haemocytometer to allow for cell 
counting.  
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2.1.2 Cell Stimulations 
 
Isolated PBMCs were plated at a concentration of 1x10
6
 cells per well in 24 well plates 
respectively (Greiner Bio-one. England, UK) in a final volume of 2 ml pre-warmed AIM-V 
media (Invitrogen). The PBMCs were treated with the different stimulants listed below to 
induce responses. 
i. Hormones 
 
Medroxprogesterone acetate (MPA), hydrocortisone, progesterone, norethisterone (NET) 
were purchased from Sigma-aldrich, and were re-suspended in 96% ethanol to a 
concentration of 10
-2
 M and stored in aliquots at -20˚C. 
Steroids were added at a final concentration of 10
-5
 M per well. The high concentration of 
steroids ensures the saturation of the receptors present in the cells. This results in all the 
receptors being bound by a hormone, and accounts for the different binding affinities of the 
hormones to their receptors. The steroids were added in the presence and absence of Bacille 
Calmette-Guérin (BCG) and anti-human anti-CD3 antibody. 
ii. BCG 
 
Mycobacterium bovis Bacille Calmette-Guérin (BCG) was grown from a stock that was given 
as a gift by Dr Léanie Kleynhans, BCG is categorised as a biosafety category two bacteria, 
and therefore all experiments conducted within a biosafety level two laminar flow cabinet. 
BCG used to stimulate cells was grown in liquid cultures of Middlebrook 7H9 broth (Difco. 
Becton Dickensen), the media was supplemented with 0,2% glycerol, 0,05% Tween 80 and 
10% oleic acid albumin dextrose catalase (OADC) enrichment media (Becton Dickensen) in 
75cm
3
 tissue culture flasks (Corning. Corning, New York) and placed in an Incubator at 
37˚C.  
Regular OD readings at 600nm were taken, until the OD readings fell within the range 0.7-
1.0 nm, indicating the start of the logarithmic growth phase. An acid fast Ziel-Neelsen (ZN) 
stain is done on an aliquot of the BCG to ensure that there was no other bacterial 
contamination present within the BCG aliquots. A 10% glycerol concentration is added to the 
liquid cultures and aliquoted into 200μl aliquots and stored at -80˚C.  
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After two days in the -80˚C freezer, the number of viable bacteria had to be determined by 
plating serial dilutions of the thawed aliquots on Middlebrook 7H11 (Difco. Becton 
Dickensen) agar plates supplemented with 0,2% glycerol and 10% OADC (Becton 
Dickensen). The inverted plates were semi-sealed in plastic bags and incubated for 3weeks at 
37˚C,after which the number of colony forming units (CFUs) were determined. The frozen 
aliquots were used in subsequent experiments ensuring the same number of bacteria at the 
same stage of growth was used in each successive experiment thus it is assumed that the 
results obtained are reproducible. 
Prior to stimulating the PBMCs an aliquot of BCG is thawed and de-clumped by being drawn 
up and down five times with a 29G syringe. Within one well of 1x10
6 
PBMCs it was assumed 
that 1 x 10
5
 macrophages (10%) were present, therefore a multiplicity of infection (MOI) of 1 
macrophage to 5 bacilli was used for experimental conditions. PBMCs were therefore 
stimulated with 5x10
5
 CFU/ml. 
ZN Stain Method 
To ensure the BCG aliquots were not contaminated a ZN stain has to be performed, method 
described below briefly. Placed a drop of the suspension onto microscope slide and allowed 
to air dry for ten minutes at 60°C, slide was heat-fixed for ten minutes at 90°C. The prepared 
slide was placed on the staining rack and flooded with carbol fuchsin (Sigma-Aldrich). The 
slide was heated to steaming point over an open flame; the slide was left to stand for five 
minutes. The fixed slide was rinsed with distilled water (dH2O) and drained. Slides were 
flooded with acid-alcohol and allowed to stand for two minutes. The dH2O rinsing step was 
repeated, and the slide flooded with methylene blue and allowed to stand for two minutes. 
The slides were rinsed with dH2O and air dried. The completed slides were examined by 
placing a drop of immersion oil onto the microscope slide and visualizing at an objective of 
100X. 
iii. Anti-CD3 
 
1x10
6 
PBMCs per well were stimulated with an anti-human CD3 antibody (eBioscience. San 
Diego, California), from here on forth it will only be referred to as anti-CD3. Anti-CD3 was 
added to the cells at a final concentration of 1µg/ml per well in the presence and absence of 
steroid hormones, cortisol, progesterone, MPA and NET.  
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After the PBMC stimulations were done with either BCG or anti-CD3 respectively. The 
supernatants and cells were harvested on different time points: Day 1, Day 3 and Day 6 and 
stored at -80ºC until subsequent analysis by enzyme-linked immunosorbent assay (ELISA), 
Luminex and RT-PCR analysis. 
2.2 Cytokine Determination 
2.2.1 ELISA 
 
ELISA was used to determine cytokine production from harvested Day1, Day 3 and Day 6 
supernatants. Two cytokines IL-12p40 (Becton Dickenson) and IFNγ (BD Pharmingen. San 
Diego, California) were selected for ELISAs.  
i. IL-12p40 ELISA 
 
A human IL-12p40 ELISA set was purchased from BD (BD Pharmingen). Ninety six well 
plates (Greiner Bio-one) were coated with 100µl purified anti-human IL-12p40 capture 
antibody overnight at 4ºC. The plates were washed with a PBS wash buffer containing 0,05% 
Tween-20 (Sigma-Aldrich) and there after blocked with assay diluent (PBS containing 10% 
Fetal Bovine Serum (FBS); (Biochrom AG. Berlin, Germany) for 1 hour at room 
temperature. Standards and cell supernatants were thawed and added to the plate in duplicate 
for 2 hours at room temperature. The detection limits of the top and bottom standards are 
2000 pg/ml and 31,3 pg/ml respectively. The plates are washed with PBS wash buffer and 
100µl working detector, consisting of biotinylated anti-human IL-12p40 detection antibody 
and streptavidin-horseradish peroxidase conjugate added, and incubated for one hour at room 
temperature. The plate was washed 7 times and 100µl Tetramethylbenzidine (TMB) substrate 
solution (Becton Dickenson) added for a final 30 minute incubation in the dark and 50µl of 
1M H2SO4 (Merck. Johannesburg, South Africa) stop solution was added prior to reading 
plate at 450nm. The absorbance was read on a Bio-Rad Benchmark Microplate Reader and 
data generated was managed through Microplate Manager Software (version 5.2, Build 103, 
Bio-Rad Laboratories). 
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ii. IFN-γ ELISA 
 
A standardized optimized protocol used within our laboratory was used to determine the level 
of IFN-γ. Brief description of ELISA protocol followed. A 96 well flat-bottomed plate 
(Greiner-Bio one) coated with 50µl of 2µg/ml of purified mouse anti-human IFN-γ capture 
antibody (BD Pharmingen) was incubated overnight at 4˚C. The next day, the plates were 
washed 4 times with wash buffer (PBS containing 0.05% Tween 20), and incubated for 2 
hours with blocking buffer buffer (PBS with 10% heat-inactivated FBS). The wash step was 
repeated prior to adding standards and samples in duplicate to wells and the plates incubated 
overnight at 4°C (IFN-γ standards were diluted in AIM-V medium, Invitrogen).The detection 
limits for the IFN-γ standard (Pharmingen recombinant IFN-γ) was 4000 pg/ml and 31 pg/ml. 
The next day, the wash step was repeated and incubated with 100µl of the 1µg/ml 
biotinylated mouse anti-human IFN-γ antibody (BD Pharmingen) for 45 minutes.  Wash step 
was repeated to remove unbound antibody and the plates incubated for 30 minutes with 100 
μl of 2.5 μg/ml Avidin Peroxidase (Sigma-Aldrich).  The final wash step was repeated prior 
to adding substrate solution, OPD tablets (Sigma-Aldrich) and incubate for 40 minutes in the 
dark to allow colour to develop. The colour development was stopped by adding 50µl of 1M 
H2SO4 (Merck). The absorbance was read on a Bio-Rad Benchmark Microplate Reader at 
450nm and the data generated managed through Microplate Manager Software (version 5.2, 
Build 103, Bio-Rad Laboratories).  
2. 3 Western Blots 
2.3.1 Lysate preparation 
 
Whole cell lysates of PBMCs were prepared in lysis buffer (20mM Tris-HCl pH 7.6, 150 mM 
sodium chloride, 1mM EDTA, 1% Triton X-100) containing Protease inhibitor cocktail 
tablets (Roche. Basel, Switzerland) and Phosphatase inhibitor cocktail 2 inhibitors (Sigma-
Aldrich). Protein concentrations were determined using Bradford method, Quick Start 
Bradford Dye Reagent (Bio-Rad).  
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2.3.2 Protein Determination 
 
For protein determination the Bradford method was used. Prior to use the dye reagent must 
reach room temperature as it is stored at 4˚C. Bovine serum albumin (BSA) (Bio-Rad) 
standards were prepared in PBS according to the table supplied by manufacturer with a range 
of 2000 - 125µg/ml. Standards were added to a 96-well plate in duplicate and samples in 
triplicate. 250µl of the dye was added to all wells. The plate was incubated in the dark for ten 
minutes at room temperature and read at a wavelength of 595nm on the Bio-Rad iMark 
microplate reader.  
2.3.3 General Western Blot procedure  
 
An 8% SDS-Page gel was prepared (H20, 30% acrylamide mix (Sigma-Aldrich), 1.5M Tris-
HCl pH 8.8, 10% SDS, 10% ammonium persulfate, Tetramethylethylenediamine (TEMED. 
Sigma-Aldrich)(Refer to Appendix A). The gel was loaded with 5µl Rainbow marker 
(RPN756V, Amersham, GE Healthcare. Wisconsin, USA). A total volume of 20µl sample 
and 5µl laemlli buffer (125mM Tris-HCl pH 6.8, 20% glycerol, 5% SDS, 2.5% β-
mercaptoethanol, 0.1% bromophenol blue) was loaded per well, containing a final protein 
concentration of 20µg. The gel was run at 50V until the running front reached the resolving 
gel, the voltage was increased to 200V and the gel continued to run at the increased voltage 
for 45minutes. Once the gel was completed the gel was transferred to the blotting unit, the gel 
‘sandwich’ was run at 100V for 45minutes. Following the blotting process the Hybond ECL 
Nitrocellulose membrane (Amersham) was placed in a TBS solution containing 5% fat free 
milk powder for overnight blocking at 4˚C. After completion of the overnight blocking step, 
the primary antibody and secondary antibody were added to the membrane respectively in a 
predetermined dilution (see 2.3.4 and 2.3.5) for 60minutes on the shaker at room temperature. 
There were 3x 10 minute wash steps each with TBS and 0.1% Tween-20 that separated the 
primary and secondary antibody steps.  
Detection of the banding pattern on the membrane was performed in the dark room through 
the addition of the chemiluminescence substance, ECL Advance Western Blotting Detection 
Kit (Amersham). Following the addition of the chemiluminescence substrate the Hyperfilm 
(Amersham) was exposed to the membrane for 20seconds prior to being developed by the 
Amersham pharmacia Biotech Hyper processor (AM4). 
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UN-SCAN-IT Graph Digitizing Software version 5.1 from Silk Scientific Corporation was 
used to digitize and extract (x,y) data values from the various Western blots. The pixel 
density data obtained was plotted in GraphPad Prism
®
 version 5.0 as a visual presentation of 
the banding pattern observed on the Western blots. 
2.3.4 Glucocorticoid and Progesterone Receptors  
 
Dilutions at which primary GR (H-300) and PR (C-19) rabbit polyclonal IgG antibodies were 
used was 1:1000, both purchased from Santa Cruz Biotechnology (Texas, USA). The ECL 
Rabbit IgG, horseradish peroxidase (HRP)-linked secondary antibody from donkey 
(Amersham) was used at a dilution of 1:5000.  
2.3.5 Kinase (ERK 1/2, p38 MAPK, JNK)  
 
The Western Blots for the kinase blots were done according to the table 2.1 listed below. The 
table below shows the dilution of the antibodies as well as the buffer in which it was diluted 
for use. All the antibodies in the table were purchased from Cell Signalling Technology 
(Massachusetts, USA). 
Table 2.1: Primary and Secondary concentrations and solutions that were used in the kinase 
Western blots. 
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2.3.6. Human Phospho-Kinase Array 
 
A Human Phospho-Kinase Array kit, Proteome Profiler™ Array (RnD Systems. 
Minneapolis, USA) was purchased for the parallel determination of the relative levels of 
protein phosphorylation of the following kinases: p38α, ERK 1/2, JNK 1/2/3, GSK-3α/β, p53, 
EGF R, MSK 1/2, AMPKα1, Akt 1/2/3, TOR, CREB, HSP27, AMPKα2, β-catenin, p70S6, 
c-Jun, Src, Lyn, Lck, STAT2, STAT 5A/B, RSK 1/2/3, eNOS, Fyn, Fgr, STAT6, STAT 5b, 
STAT 3, p27, PLC-γ1, Hck, Chk-2, FAK, PDGF Rβ, WINK1, PYK2 and Hsp60. Within the 
array the capture antibodies have been spotted in duplicate on nitrocellulose membranes. Cell 
lysate samples were diluted and mixed with a cocktail of biotinylated detection antibodies 
(supplied in kit). The sample and antibody mixture was incubated with the nitrocellulose 
membranes. Any protein that is present will bind to its associated capture antibody on the 
membrane. Streptavidin-Horseradish Peroxidase and chemiluminescent detection reagents 
were added, and the signal that was produced was in proportion to the amount of kinase that 
was bound. The chemiluminescence of the nitrocellulose membranes was detected in the 
same manner as a Western blot (section 2.3.3). 
2.4 Receptor Expression  
  
The chart below (figure 2.1) depicts the sample preparation process that was followed with 
the sample preparation from the stimulated PBMC samples to determine GR, PR, AR, mPR-
α, mPR-β, mPR-γ and PGRMC1 expression levels. Real-Time PCR assay was run on the 
ABI Applied Biosystems 7900HT Fast Real-Time PCR System.  
 
Figure 2.1: Sample process followed for the preparation of PBMC samples for the RT-PCR run. 
Detailed explanation of the procedures followed for the PBMC samples are described below: 
1 x 106 
PBMC's 
RNA Isolation 
RNeasy®Mini Kit 
(Qiagen. 
California, USA) 
cDNA 
Construction 
ImProm-II™ 
Reverse 
Transcription 
System 
(Promega. 
Wisconsin, USA) 
Real Time 
PCR  
KAPA SYBR FAST 
qPCR Master Mix 
(2x) (Kapa 
Biosystems. Cape 
Town, South 
Africa) 
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2.4.1 RNA Isolations 
 
The RNA was isolated from the PBMC samples using the RNeasy®Mini Kit (Qiagen). The 
standard protocol supplied by the manufacturer was optimized to produce the highest yield of 
RNA from the samples. Below is a brief outline of the protocol that was followed. 
One million PBMCs per well was placed in a 24 well tissue culture plate and stimulants were 
added to AIM-V media and the cells were harvested at 1, 3 and 6 days post stimulation. The 
cells were harvested into a 1.5ml eppendorf tubes (Merck) and spun down at 1500rpm for 5 
minutes, all supernatant was removed with aspiration. The cell pellet was disrupted by adding 
350µl RLT Buffer (supplied in kit) and vortexed for 1 minute to homogenize the cell lysate 
and then placed on ice for 3 minutes. After the incubation on ice, 350µl of a 70% ethanol 
solution was added to the cell lysate and mixed well through pipetting up and down. The 
sample was transferred to an RNeasy spin column and centrifuged for 1 minute at 15 000 
rpm, the flow through was discarded from the spin column. The spin column was washed by 
adding 700µl RW1 Buffer to the column and centrifuged for 45 seconds at 15 000 rpm, flow 
through was discarded carefully to avoid contact with the spin column. The spin column 
membrane was washed by 500µl RPE Buffer, centrifuged at 15 000 rpm for 45 seconds, and 
flow through discarded. This final wash step was repeated with a prolonged centrifugation 
time of 2 minutes, the longer centrifugation step serves to dry out the membrane before the 
elution step. The RNeasy spin column was transferred to a new 1.5ml collection tube, and 
35µl RNase-free water was added directly to the spin column membrane and placed on ice 
for 3 minutes before centrifuging for 1 minute at 15 000rpm. 
The final elution contains the isolated RNA sample. An addional DNase treatment step was 
required to remove DNA contaminants in the isolated RNA sample. A TURBO DNA-free™ 
DNase Treatment Ambion kit (Applied Biosystems, Life Technologies. California, USA) was 
purchased. The procedure followed is outlined below. 
1µl of TURBO DNase was added to RNA sample and incubated at 37ºC for 30 minutes. 
After the incubation period 2µl of DNase Inactivation Reagent was added and mixed well 
prior to incubation at room temperature for 5 minutes. The reagents were mixed occasionally 
by flicking the tube 2-3 times during the incubation period. The tube was centrifuged for 90 
seconds at 10 000g. The DNase Inactivation Reagent forms a pellet at the bottom of the tube 
and the supernatant was transferred to a new tube.  
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The concentration of RNA in each sample was determined through nanodrop technology on 
the Nanodrop ND-100 machine (Inqaba Biotec. Pretoria, South Africa). A260/A280 ratio of 2 
was considered a pure RNA sample.  
2.4.2 Hotstart PCR 
 
To verify that a pure RNA sample was isolated from the PBMCs, a Hotstart (Qiagen) PCR 
following manufactures protocol was performed using GAPDH primers (IDT. Iowa, USA). 
The PCR products were run on a SDS-PAGE gel at 100V for 1,5 hours. The gel was 
visualised using the Gel Doc system V-Box. The absence of bands within the gel apart from 
the positive control, indicate that the RNA sample was pure and does not contain DNA 
contamination. 
2.4.3 cDNA library construction 
 
The RNA isolated from the PBMC samples was used to construct cDNA to be used in Real 
Time PCR assays. A commercially available Promega kit ImProm-II™ Reverse 
Transcription System (Promega) was purchased.  
The 5µl of experimental RNA solution used was composed of the following components; 4µl 
of target RNA and 1µl oligo-dT receptor primer. The RNA and primer mixture were placed 
in a preheated 70ºC heat block for 5 minutes then placed on ice for 5 minutes. After which 
the tubes were spun down for 10 seconds in a microcentrifuge to collect all condensate.  
Reverse Transcription reaction mixture was made up as described below (Table 2.2) and 15µl 
of the reaction mixture was added to reaction tubes on ice. The 5µl of experimental RNA was 
added to the 15µl RT reaction mixture to render a final 20µl working volume. 
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Table 2.2: Composition of the Reverse Transcription mixture used in the Promega ImProm-II 
kit. 
 
The PCR tubes were placed in an ABI Applied Biosystems Veriti 96 well thermal cycler PCR 
machine that has been programmed with the following protocol: 5minutes at 25˚C, 42 
minutes at 42˚C and 15 minutes at 70˚C. 
The concentration of DNA in each sample was determined through nanodrop technology on 
the Nanodrop ND-100 machine (Inqaba Biotec. Pretoria, South Africa). A260/A280 ratio of 
1.8 was considered a pure DNA sample.  
2.4.4 Real Time-PCR 
 
The conditions for the Real Time-PCR were adapted from published data (68). The samples 
used for qPCR analysis, were prepared according to the protocol supplied by Manufacturer of 
KAPA SYBR FAST qPCR kit Master Mix (2x) ABI Prism (Kapa Biosystems). 
After optimization the protocol implemented for the SYBR Green Real-Time PCR assay was 
an initial denaturation step of 10 minutes at 95˚C, the amplification step involved 40 cycles of 
15 seconds at 95˚C and 1 minute at 60˚C. The final dissociation step was 1 cycle of 1 minute 
at 95˚C, 2 minutes at 60˚C and 15 seconds at 95˚C. 
The following sense and antisense (5’ – 3’) primer sequences were used for amplification 
during the RT-PCR runs:  
PR, AAATCATTGCCAGGTTTTCG and TGCCACATGGTAAGGCATAA; 
PGRMC1, TATGGGGTCTTTGCTGGAAG and GCCCACGTGATGATACTTGA;  
mPR-α, TCAGACCTGGCGCTTCTATT and AGGTGAAAGAGGCAAGGACA;  
mPR-β, CACGAAGGACCCACAAAACT and CAATCCCAAGCACCACCTAT;  
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mPR-γ, ACTATGGTGCCGTCAACCTC and CAGAGTCTGGGCTTCTGGAC;  
GR, CCTAAGGACGGTCTGAAGAGC and GCCAAGTCTTGGCCCTCTAT;  
AR, CCTGGCTTCCGGGCAACTTACA and GGACTTGTGCATGCCGTACTCA. 
 Gene- specific expression of the target gene sequence transcripts were normalized to the 
expression of housekeeping gene;  
GAPDH, TGAACGGGAAGCTCACTGG and TCCACCACCCTGTTGCTGTA. 
The receptor expression is depicted in the graphs as a fold change of the ΔCt values. The ΔCt 
values were calculated using the following formula; ΔCt= 2
(Ct(Target) – Ct (Reference)) 
, the 
reference gene used here was GAPDH. The fold change was calculated by dividing the ΔCt 
of the stimulatory condition (e.g. anti-CD3) with the ΔCt of the US group.  
2.5 Luminex Multiplex Assays 
 
2.5.1 Cytokine Assay 
 
Multianalyte profiling was performed on the Bio-Plex™ Suspension Array System (Bio-Rad 
Laboratories. California, USA). Microspheres used for calibration, as well as sheath fluid 
used during assay were purchased from Bio-Rad. 
To determine the multiple cytokine expression levels of the PBMCs under different 
stimulatory conditions, namely anti-CD3 and BCG, a 13-plex cytokine kit (MPXHCYTO-
60K-13. Merck-Millipore. Massachusetts, USA) was used to measure the following 
cytokines: Granulocyte colony-stimulating factor (G-CSF), IFN-γ, IL-1α, IL-1β, IL-2, IL-4, 
IL-6, IL-8, IL-10, IL-12(p40), IL-12(p70), IL-13 and TNF-α. 
2.5.2 Phosphoprotein Signalling Assays 
 
The cell lysates that were used for the phosphoprotein signalling kits were prepared as 
follows: 
The harvested cells were pelleted, the supernatant removed and the cell pellet washed through 
re-suspension in ice cold tris buffered saline (TBS) and centrifuged. The supernatant was 
discarded and cell pellet re-suspended in 100µl ice cold 1x Milliplex MAP lysis buffer 
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containing freshly prepared protease inhibitors (Roche). Cell lysates are rocked gently at 4ºC 
for 15minutes, before the cell lysates are stored at -80ºC for analysis on Luminex assays. 
The signalling cascades were analysed by two different phosphoprotein multiplex signalling 
assays, 7-plex T Cell Receptor Signalling Kit: CD3ɛ, CREB, ERK/MAPK 1/2, LAT, Lck, 
Syk, ZAP-70 (48-690. Merck-Millipore); and an 8-Plex Multi-pathway Signalling Kit: 
CREB, ERK/MAPK 1/2, IĸBα, JNK/SAPK1, STAT3, STAT5A/B, p38/SAPK2A/B, p70S6 
kinase (48-680. Merck-Millipore). The TCR signalling assay measures the differences in the 
TCR signalling cascade under different stimulatory conditions. The Multi-pathway kit covers 
more general signalling cascades that can signal through the receptor tyrosine kinases and 
activates different signalling cascades other than the TCR pathway. 
Manufacturer’s instructions were followed to perform the Luminex assay. In brief, from 
reconstituted standard a standard curve ranging from 3.2 pg/ml to 10 000 pg/ml was prepared. 
The filter plate was pre-wet for ten minutes with assay buffer which was discarded by 
vacuum aspiration. Assay buffer was added to all sample wells and AIM-V medium 
(Invitrogen) to the standard wells. Standards and two quality controls included in the kits and 
samples were added in duplicate to the pre-wet plate followed by antibody coated fluorescent 
beads. The plate was incubated on an orbital shaker for one hour at room temperature. The 
wells were emptied by vacuum and the plate washed with Wash buffer (supplied in kit). The 
biotinylated detection antibody was added and the plate incubated for 30 minutes on the 
shaker. The Streptavidin-Phycoerythrin was added and the plate again incubated for 30 
minutes. After washing the plate twice with wash buffer, sheath fluid was added to all the 
wells and placed on shaker for five minutes, after which the  plate was read immediately on a 
Bio-plex platform (Bio PlexTM, Bio Rad Laboratories), using a 5PL regression curve.  
Manufacturer’s instructions were followed to perform the Luminex assay. The protocol was 
similar to the one described above with the following alterations. After addition of cell 
lysates the plate was placed on an orbital shaker overnight at 4˚C. After the biotinylated 
detection antibody was added and the plate was incubated for 1 hour on the shaker. The 
Streptavidin-PE was added and the plate incubated for 15 minutes, followed by the addition 
of 25µl Amplification buffer for 15 minutes on the shaker in the dark. 
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2.6 Statistical Analysis 
 
ELISA results were analysed in GraphPad Prism
®
 version 5.0, and all graphs shown display 
the mean ± standard error of the mean (SEM). Statistical analysis performed on all results 
was a one-way analysis of variance (ANOVA) with a Bonferroni post hoc test. Statistical 
analysis on the Luminex and RT-PCR results was performed with the assistance of Prof. 
Martin Kidd (Centre for Statistical Consultation, University of Stellenbosch) using Statistica 
version 11, Statsoft. An ANOVA followed by a Fisher’s least significant difference (LSD) 
post hoc test was done. The vertical bars on graphs depict the 0.95 confidence intervals (CI). 
A p-value less than or equal to 0.05 was accepted to be significantly different.  
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Chapter 3: Results 
3.1 Introduction 
 
Steroid hormone binding receptors can be found on the plasma membrane, in the cytosol and 
also in the nucleus of target cells. The receptors are located intracellularly (cytoplasmic) and 
initiate signalling cascades for steroid hormones which lead to changes in gene expression, 
these genomic effects are not immediate and take hours to days. The glucocorticoid receptor 
(GR) is a ubiquitously expressed transcription factor that mediates the effects of GCs and 
regulates the genes that play a role in development, metabolism, and immune response (29). 
The GR induces or represses the expression of genes in response to GCs, mediating such 
processes as apoptosis and cell growth and differentiation. The progesterone receptor (PR) is 
a protein found inside cells, and is activated by the steroid hormone progesterone. The effects 
of progesterone are mediated by two functionally different isoforms of the progesterone 
receptor, PR-A and PR-B (51). 
 
Figure 3.1 shows a diagram of the ability of the hormones to bind to the different hormone 
receptors, the binding of cortisol and MPA to the GR leads to the inhibition of transcription 
and the suppression of cytokine secretion.  
 
Figure 3.1: Schematic representation of the ability of the different hormones, cortisol, MPA, Progesterone 
and NET to interact with the glucocorticoid receptor (GR) and progesterone receptor (PR). 
Cortisol (cort) can only bind to the GR. Both Progesterone (prog) and NET, only bind to the PR. Whereas, 
MPA, can bind to both the GR and the PR. Once the hormone binds to the receptor, it moves into the nucleus, 
where it binds to the DNA, and inhibits gene transcription, thus reducing the expression of cytokine profiles.  
 
 Expression of cytokine profiles 
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In my study the effect of the hormones cortisol, progesterone, MPA and NET on the secretion 
of cytokines and phosphorylation of signalling molecules was determined after stimulation 
with BCG and anti-CD3 respectively. PBMCs were stimulated with BCG to induce an 
antigen specific response, which occurs through recognition of the antigen bound to MHC on 
antigen presenting cells by the T-cell receptor (TCR) complex. This form of stimulation also 
leads to co-receptor activation and activation of more complex signal transduction cascade 
besides TCR signalling. Leading to cellular responses aimed at eliminating the encountered 
pathogens. Antigen presentation forms part of the acquired immune system. Whereas anti-
CD3 stimulation induces a non-specific response, which only leads to TCR activation and 
signalling without co-receptor activation. The cells of the innate immune system recognize 
and react to encountered pathogens in a non-specific way, by recruiting immune cells to sites 
of infection through the production of cytokines. 
Cytokines are a group of soluble proteins that act as regulators to control activities of 
individual cells and tissues. Cytokines can mediate the interactions between cells directly and 
are able to regulate processes taking place in the extracellular environment. Upon activation 
of a T-cell it can lead to different outcomes, it can alter the production of transcription gene 
products, T-cell differentiation, T-cell proliferation and cytokine secretion. Figure 3.2 is a 
graphic representation of the interaction between the GR and the TCR and the downstream 
signalling molecules involved. Refer to section 1.3.2 for the description of the components 
involved. 
 
Figure 3.2: Schematic representation of the different kinases involved in the TCR signalling cascade upon 
T-cell activation, the blocks indicate the analytes analysed in the 7-plex Luminex panel. 
 
 
 
 
 
 GR
R 
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The TCR signalling pathway is not the only means of signalling, cells can respond to their 
environment in a variety of different ways through intracellular signalling pathways. 
Signalling through Receptor Tyrosine kinases (RTK) often promote increased metabolism 
and cell growth. The activation of ERK/MAP kinase is one of the key Ser/Thr kinases 
activated via the RTK signalling pathway, promoting increased activity of p70 S6 kinase, 
Msk1, STAT3, CREB, and other signalling molecules. Other signalling pathways induced via 
stress can promote p38, JNK, and Iκβ signalling (figure 3.3). Refer to section 1.3.2.1 for a 
detailed explanation of the components involved in these pathways.  
 
Figure 3.3: Schematic representation of the kinases and transcription factors analysed in the Multiple 
Signalling pathway kit with an indication of the pathway involved. 
3.2 Experimental Design  
 
Whole blood samples were collected from non-contraceptive users and PBMCs were isolated. 
The PBMCs were stimulated for 1, 3 and 6 days respectively with anti-CD3 (1µg/ml) and 
BCG at a multiplicity of infection (MOI) of 5:1. The isolated cells were stimulated with high 
concentrations (10 μM) of MPA and NET as well as the endogenous hormones cortisol and 
progesterone. The effect of the addition of the hormones to the stimulated cells was observed 
by the alterations in the anti-CD3 induced and BCG induced cytokine secretion, receptor 
expression levels and phosphorylation of signalling molecules. The supernatants of the 
stimulated cells were harvested for ELISA and Luminex assays. The cells were harvested and 
the same cell lysates were used for both the 7-plex and 8-plex Luminex signalling assays. 
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PBMCs from the same patients were used for the cell stimulations from which RNA was 
isolated for the RT-PCR experiments performed. 
3.3 Effect of hormones on cytokine secretion in human PBMCs 
3.3.1 The effect of the hormones cortisol, MPA, progesterone and NET on 
BCG and anti-CD3 induced cytokine secretion in human PBMCs 
 
A Multiplex bead array assay was used to assess the cytokine production from supernatants 
collected from stimulated PBMCs isolated from whole blood samples of woman not currently 
receiving any steroid treatment or using any hormone based contraception method. The 
Luminex panel revealed that alterations occurred in the secretion profiles of the different 
cytokines under the different stimulations. 
The results of three cytokines namely, IL-2, IL-4 and IL-8 have not been reported on in 
section 3.3.1. They were excluded as the detected levels for IL-2 and IL-4 were below the 
detectable ranges specified within the manufacture’s guidelines. High background was 
detected for the IL-8 bead, thus we deemed that the results were not reliable and was 
excluded from the results section.  
i. IL-1α 
 
Cortisol and MPA significantly suppressed the anti-CD3 induced production of IL-1α for 
both day 3 and day 6 time points (figure 3.4 a, c). Although not statistically significant it can 
be seen that the anti-CD3 induced production of IL-1α was supressed in the progesterone and 
NET stimulations for both time points. The cortisol and MPA stimulations showed 
suppression of the anti-CD3 induced IL-1α production compared to progesterone and NET 
stimulations which did not suppress the IL-1α production. The addition of cortisol 
significantly suppressed the BCG induced production of IL-1α for both day 3 and day 6 time 
points (figure 3.4 b, d). The BCG induced production of IL-1α was suppressed by MPA, 
progesterone and NET stimulations for both time points, however only MPA on day 6 
reached a level of statistical significance. The IL-1α production induced by BCG was 
significantly inhibited by cortisol when compared to MPA. Both cortisol and MPA showed 
more inhibition on the IL-1α BCG induced production when compared to progesterone and 
NET stimulations. 
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Thus it can be seen that MPA mimics the glucocorticoid activity of cortisol while NET 
mimics progesterone. 
 
Figure 3.4: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-1α 
secretion. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. Unstimulated (US), BCG, BCG + all four hormone groups, 
n=2. US, anti-CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, 
n=1. All were performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher least 
significant difference (LSD) post hoc test and presented as mean ± SEM. The letters a, b, c and d indicate 
statistical significance, where values with the same letter are not significantly different. 
 
ii. IL-1β 
 
The cortisol and MPA stimulations significantly inhibited the anti-CD3 induced production 
of IL-1β for day 3 (figure 3.5a). The anti-CD3 induced production of IL-1β was inhibited by 
progesterone and NET stimulations for both time points levels were not statistically 
significant (figure 3.5b). Cortisol and MPA stimulations showed inhibition of the IL-1β 
production induced by anti-CD3, progesterone and NET stimulations did not inhibit the IL-1β 
to the same extent. 
At both day 3 and day 6 time points cortisol significantly suppressed the BCG induced 
production of IL-1β (figure 3.5 b, d). The BCG induced production of IL-1β was inhibited in 
the MPA, progesterone and NET stimulations for both the time points, although on day 6 a 
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level of statistical significance was reached in MPA stimulation. The IL-1β BCG induced 
production was suppressed by cortisol and MPA stimulations when compared to progesterone 
and NET stimulations which did not inhibit the BCG induced production of IL-1β to the same 
extent. Therefore it can be concluded that cortisol and MPA has a suppressive effect on the 
anti-CD3 induced production of IL-1β more than progesterone and NET stimulations. MPA 
mimics the effect of cortisol, more than that of progesterone. 
 
 
Figure 3.5: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-1β 
secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b, c and d indicate statistical significance, where values with the same 
letter are not significantly different. 
 
iii. IL-6 
 
At both day 3 and day 6 (figure 3.6 a, c), cortisol and MPA significantly inhibited anti-CD3 
induced IL-6 expression. Progesterone and NET stimulations did not exhibit an inhibitory 
effect on the anti-CD3 induced IL-6 production. 
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For both day 3 and day 6 time points the BCG induced IL-6 production was significantly 
suppressed by cortisol and MPA at both time points (figure 3.6 b, d).  The IL-6 production 
induced by BCG was not inhibited by progesterone and NET stimulations.   
Therefore cortisol and MPA have a suppressive effect on the BCG and anti-CD3 induced 
production of IL-6. However, progesterone and NET no suppressive effect on the BCG and 
anti-CD3 induced IL-6 production. 
 
 
Figure 3.6: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-6 
secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b and c indicate statistical significance, where values with the same 
letter are not significantly different. 
 
iv. IL-10 
 
The anti-CD3 induced production of IL-10 was inhibited by cortisol, MPA, progesterone and 
NET (figure 3.7 a, c). The cortisol and NET inhibition on the anti-CD3 induced IL-10 
secretion reached a significant level at day 3.  
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The BCG induced IL-10 production was significantly suppressed by cortisol at day 3 and day 
6 time points (figure 3.7 b, d). MPA significantly suppressed the BCG induced secretion of 
IL-10 in a similar way to cortisol at day 6. The BCG induced IL-10 secretion of progesterone 
and NET stimulations were higher than those of cortisol and MPA stimulations at day 6.  
From the findings it can be seen that in the BCG stimulations at the earlier time points the 
synthetic progestins mimic progesterone, as they do not show the same suppressive effect on 
the production of IL-10 as is seen with cortisol.  
 
Figure 3.7: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-10 
secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b and c indicate statistical significance, where values with the same 
letter are not significantly different. 
v. IL-12p40 
 
The anti-CD3 stimulations on day 3 and day 6 time points had very low production of 
IL12p40 (figure 3.8 a, c). It could be said that the detectable levels of IL-12p40 were too low 
to be detected. However, the pattern of inhibition remains consistent even at the low detection 
levels.  
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The BCG induced IL-12p40 secretion was significantly inhibited by cortisol and MPA 
stimulation at both the day 3 and day 6 time points (figure 3.8 b, d). The BCG induced 
secretion of IL-12p40 was significantly suppressed by progesterone and NET stimulations for 
day 3, however the level of inhibition did not reach a level of statistical significance on day 6. 
Cortisol and MPA showed significantly higher inhibition levels of BCG induced production 
of IL-12p40 in comparison with progesterone and NET stimulations. From the BCG 
stimulation it can be seen that IL-12p40 was mainly affected by the cortisol and MPA 
addition. 
 
Figure 3.8: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-12p40 
secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b and c indicate statistical significance, where values with the same 
letter are not significantly different. 
 
vi. IL-12p70 
 
The anti-CD3 induced IL-12p70 secretion was significantly suppressed by cortisol and MPA 
day 3 (figure 3.9a).  The detectable levels of IL-12p70 were very low for day 6 post 
stimulation (figure 3.9c). 
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Cortisol and MPA stimulations significantly inhibited the BCG induced production of IL-
12p70 for both day 3 and day 6 time points (figure 3.9 b, d). The production of the BCG 
induced IL-12p70 was suppressed in the progesterone and NET stimulations for both the time 
points, however the difference in IL-12p70 inhibition did not reach a level of statistical 
significance for day 6. Inhibition of IL-12p70 by cortisol and MPA was significantly lower 
than the progesterone and NET inhibition. 
It can be seen that in the case of IL-12p70 secretion that MPA mimics cortisol with the 
inhibition seen in both the BCG induced and anti-CD3 induced stimulations.  
 
Figure 3.9: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-
12p70 secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b, c and d indicate statistical significance, where values with the same 
letter are not significantly different. 
 
vii. IL-13 
 
Cortisol and MPA stimulations significantly inhibited the anti-CD3 induced secretion of IL-
13 for both the day 3 and day 6 time points (figure 3.10 a, c). Although the anti-CD3 induced 
IL-13 inhibition by progesterone is statistically significant it can be seen that the production 
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of IL-13 was supressed by NET as well for both time points. However, cortisol and MPA 
stimulations showed higher suppression levels of the anti-CD3 induced IL-13 production than 
was seen with progesterone and NET. 
The addition of cortisol and MPA to BCG infected cells significantly suppressed the 
production of IL-13 when compared to BCG for both the day 3 and day 6 time points (figure 
3.10 b, d). The inhibition of cortisol and MPA on the BCG induced secretion of IL-13 was 
significantly lower compared to the level of inhibition of IL-13 induced secretion of 
progesterone and NET stimulations. Therefore it can be seen that the addition of cortisol and 
MPA suppresses the secretion of IL-13 to a greater extent than can be observed with the 
addition of progesterone and NET to the stimulations. This strengthens the notion that MPA 
mimics cortisol rather than progesterone. 
 
Figure 3.10: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IL-13 
secretion. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. Unstimulated (US), BCG, BCG + all four hormone groups, 
n=2. US, anti-CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, 
n=1. All were performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post 
hoc test and presented as mean ± SEM. The letters a, b and c indicate statistical significance, where values with 
the same letter are not significantly different. 
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viii. IFN-γ 
 
Cortisol and MPA suppressed the anti-CD3 induced production of IFN-γ at both the day 3 
and day 6 time points (figure 3.11 a, c). It can be seen that the anti-CD3 induced production 
of IFN-γ was supressed in both progesterone and NET stimulations for both time points. The 
cortisol and MPA stimulations showed higher suppression levels of the anti-CD3 induced 
IFN-γ production at day 6 than the progesterone and NET stimulations. 
The addition of cortisol to BCG significantly suppressed the production of IFN-γ at both the 
time points (figure 3.11 b, d). The production of IFN-γ was suppressed by the addition of 
MPA, progesterone and NET to BCG stimulations for both the time points, however the 
difference in IFN-γ did not reach a level of statistical significance. The suppression of BCG 
induced IFN-γ production by cortisol showed significant levels of inhibition compared to the 
progesterone and NET. 
Therefore the addition of cortisol and MPA suppresses the secretion of IFN-γ to a greater 
extent than the addition of progesterone and NET to the stimulations. 
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Figure 3.11: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced IFNγ 
secretion.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b, c and d indicate statistical significance, where values with the same 
letter are not significantly different. 
 
ix. TNF-α 
 
The production of TNF-α was also suppressed with the addition of cortisol and MPA to the 
anti-CD3 stimulations (figure 3.12 a, c). The level of inhibition on anti-CD3 induced TNF-α 
secretion reached statistical significance for cortisol for both day 3 and day 6, however MPA 
was only significant at day 3. The anti-CD3 induced TNF-α secretion was significantly 
suppressed by progesterone and NET at day 3.  
The BCG induced production of TNF-α was significantly inhibited by the addition of cortisol 
and MPA for both day 3 and day 6 time points (figure 3.12 b, d). The TNF-α production 
induced by BCG was significantly inhibited by cortisol and MPA when compared to the BCG 
induced secretion of TNF-α by progesterone and NET stimulations. The effect of cortisol and 
MPA thus can be said to have a greater inhibitory effect on the secretion of TNF-α than the 
inhibitory effect observed with the addition of progesterone and NET to the BCG and anti-
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CD3 stimulations. Again MPA appears to have more glucocorticoid activity compared to 
protestogenic activity. 
 
Figure 3.12: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced TNF-α 
secretion. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b, c and d indicate statistical significance, where values with the same 
letter are not significantly different. 
 
x. G-CSF 
 
The anti-CD3 induced G-CSF secretions pattern for cortisol, MPA, progesterone and NET for 
both day 3 and day 6 time points (figure 3.13 a, c) showed elevated levels but where not 
significant. 
Cortisol inhibited the BCG induced production of G-CSF, whereas MPA, progesterone and 
NET did not exhibit the same inhibitory effect on the G-CSF secretion at day 3 (figure 
3.13b). At day 6 the BCG induced G-CSF secretion was enhanced by the addition of cortisol 
and MPA, but not the addition of progesterone and NET (figure 3.13d).The secretion pattern 
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of G-CSF did not show the distinct pattern seen throughout this section, where cortisol and 
MPA inhibit the cytokine production. 
 
Figure 3.13: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced G-CSF 
secretion. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG (b&d) or 1µg/ml anti-
CD3 (a&c) respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone 
and NET. The cytokine concentration was measured in culture supernatant, collected 3 and 6 days post-
stimulation, with a 13-plex cytokine Luminex panel. US, BCG, BCG + all four hormone groups, n=2. US, anti-
CD3, n=2. Anti-CD3 + all four hormone groups, n=3. Cortisol, MPA, progesterone and NET, n=1. All were 
performed in duplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as mean ± SEM. The letters a, b, c and d indicate statistical significance, where values with the same 
letter are not significantly different. 
 
Summary: 
 
The cytokine data described within this secretion shows that with regard to cytokine 
production, MPA mimics the endogenous hormone cortisol by suppressing the cytokine 
production. Whereas NET seems to mimic the effects of progesterone, thus does not have the 
same degree of cytokine suppression as is seen with MPA. These observations could suggest 
that MPA has glucocorticoid properties that are not present with NET. 
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3.4 GR and PR protein expression in PBMCs 
 
In section 3.3 it was shown that certain cytokine secretion profiles were inhibited by the 
addition of cortisol and MPA to BCG and anti-CD3 stimulations. In order to determine 
through which steroid receptors the hormones mediate their action, we aimed to measure the 
levels of steroid receptors in PBMCs. We used two different approaches: 
a) Western blot for protein receptors where antibodies were available to us for the GR 
and PR.  
b) RT-PCR for the mRNA levels of the GR, PR, AR, mPRα, mPRβ, mPRγ and 
PGRMC1. 
The receptor expression was determined using Western Blot analysis of neat cell lysates. The 
expression of the two receptors within the PBMCs will provide insight into whether there are 
receptors available within our cells for hormone interaction. Figure 3.1 shows a schematic 
representation of the hormones ability to interact with the receptors. 
i. Glucocorticoid receptor  and progesterone receptor expression in PBMCs 
 
The GR (H-300) antibody used in our experiments is recommended for detection of GRα 
(MW: 95 kDa) and GRβ (MW: 90 kDa). The PR (C-19) antibody used in our experiments is 
recommended for detection of PR-A (MW: 81kDa) and PR-B (MW: 116 kDa). 
 
The PBMC cells expressed the GR receptor (figure 3.14a). The band was detected at 
approximately 97kDa, this could be accounted to the close proximity of the two GR isoforms 
(GRα, 95 kDa and GRβ, 90 kDa), thus too close together to be clearly distinguished as two 
separate bands. The presence of the GR receptors within the cells confirms that the hormones 
used within our stimulations could mediate their effects via the GR. 
The level of PR expression was not detectable by Western blot in the PBMCs (figure 3.14b). 
This could potentially be attributed to, too low PR numbers to be picked up at protein level, 
but could be detectable at RNA level.  
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Figure 3.14: Western Blot representing (a) GR (b) PR banding pattern in PBMC cells. 
a) 20µg and 40µg PBMC cell lysates were subjected to SDS-PAGE and proteins transferred to hybond ECL 
membranes. Blot probed with a 1:1000 of the GR-reactive and PR-reactive rabbit polyclonal antibodies 
respectively. Followed by the incubation with 1:5000 of the Rabbit IgG HRP-linked secondary antibody. Blots 
were visualized by treatment with chemiluminescent reagents followed by exposure to light-sensitive film. 
Samples yielded a single prominent band at approximately 97 kDa (GR) and 116kDa (PR).  
 
The absence of detection of the classical PR by Western blot in PBMCs could be due to the 
low detectable protein levels and has previously been reported (58)(68). This signifies that 
the effects of progesterone and NET are possibly mediated through membrane bound 
progesterone receptors such as mPRα, mPRβ, mPRγ and PGRMC1. Antibodies to these 
receptors are not commercially available. Therefore we performed RT-PCR to ascertain the 
presence of those receptors in PBMCs. The presence of the GR within the PBMC cells 
supports the cytokine data seen in section 3.1 where inhibition of cytokine production was 
observed. This could potentially be due to cortisol and MPA hormones binding to the GR 
3.5 The effect of the hormone cortisol, MPA, progesterone and NET on 
BCG and anti-CD3 induced alterations in receptor mRNA levels in 
human PBMCs  
 
Our aim was to confirm the Western blot results by Real Time PCR to see whether the GR 
and PR mRNA levels correspond with what was seen in the Western blot. Additionally we 
wanted to evaluate expression levels for other steroid receptors such as AR, mPRα, mPRβ, 
mPRγ and PGRMC1 for which no commercial antibodies are available. As well as determine 
the effect of BCG and anti-CD3 stimulations on the mRNA levels of the various receptors. 
To determine the effect that the hormones, cortisol, progesterone, MPA and NET have on the 
expression of steroid receptors after stimulation with BCG and anti-CD3 respectively. A Real 
Time PCR assay was used to determine the receptor expression from PBMCs isolated from 
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whole blood samples of woman not currently receiving any steroid treatment or using any 
hormone based contraception method. The Real Time PCR revealed that alterations occurred 
in the receptor expression profiles of the different steroid receptors under the different 
stimulatory conditions. 
Results were normalized relative to expression in unstimulated (US) cells and are expressed 
as fold change from basal levels (=1) and this is indicated on the graphs by means of a 
reference line on the vertical y-axis. All the stimulatory conditions are explained in reference 
to the US sample, a fold change value above 1 will indicate an increase in the expression of 
the receptor. A value below 1 will indicate a decrease in the receptor expression compared to 
basal levels. 
i. GR 
 
At day 1 post anti-CD3 stimulations no significant observations were made for the GR 
expression (figure 3.15a). The day 3 stimulations (figure 3.15c) reveal that MPA treatment 
induced significantly higher GR levels when added together with anti-CD3 compared to 
progesterone and NET. The progesterone only stimulation had significantly higher GR 
expression when compared to progesterone and NET stimulations in the presence of anti-
CD3. The addition of cortisol to cells stimulated with anti-CD3 resulted in higher expression 
levels of GR in comparison with progesterone and NET GR expression levels. Although a 
difference in expression was observed it was not statistically significant. At day 6 post 
stimulation the MPA stimulation led to significantly higher levels of GR in comparison with 
anti-CD3 stimulations that included the addition of cortisol, MPA, progesterone and NET, as 
well as the NET only stimulation (figure 3.15e).  
The stimulations with BCG for day 1, 3 and 6 had expression levels below the basal levels. 
Day 1 post BCG stimulation the addition of MPA and progesterone had significantly higher 
GR expression levels when compared to the addition of cortisol and NET (figure 3.15b). The 
addition of MPA to BCG stimulation had significantly higher GR expression when compared 
to the hormone only stimulations of cortisol, MPA, progesterone and NET. The addition of 
progesterone to the BCG stimulation produced significantly higher GR expression when 
compared to the addition of cortisol to BCG. The hormone only stimulations cortisol, MPA, 
progesterone and NET showed significantly lower GR expression when compared to the 
BCG induced progesterone and MPA GR expression levels. Day 3 post stimulation time 
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point shows no significant differences for the BCG stimulations (figure 3.15d). The changes 
in GR expression for day 6 post stimulation shows that the addition of progesterone to BCG 
produced significantly higher GR expression levels when compared to the addition of cortisol 
and MPA to BCG (figure 3.15f). The hormone only stimulations cortisol, MPA, progesterone 
and NET, displayed significantly lower receptor expression when compared to the addition of 
progesterone to BCG stimulation GR expression levels. 
The BCG stimulations all had expression levels below the basal levels indicating decreased 
GR expression levels. The anti-CD3 simulations revealed that the addition of MPA or MPA 
by itself increased the GR expression levels of the stimulated cells. 
  
Figure 3.15: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced GR 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulation conditions, experiments were run in 
triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented as 
least-squares means and 95% confidence intervals. The letters a, b and c indicates statistical significance, where 
values with the same letter are not significantly different from each other.  A P value of 0.05 was regarded as 
significantly different. 
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ii. PR 
 
Post anti-CD3 stimulation at day 1, revealed no significant changes in the PR expression 
levels (figure 3.16a).  The changes in the PR expression for day 3 (figure 3.16c) showed that 
the progesterone only stimulation had a PR expression level that was significantly higher than 
the PR expression of the anti-CD3 stimulation with added cortisol, MPA, progesterone, NET, 
as well as the hormone only stimulations cortisol, MPA and NET. For the anti-CD3 
stimulations on day 6 post stimulation there were no statistically significant differences in PR 
expression observed (figure 3.16e).  
From the PR expression for the BCG day 1 post stimulation (figure 3.16b), the addition of 
MPA to BCG showed significantly higher PR expression levels when compared to the BCG 
induced cortisol and NET levels. The hormone only stimulations cortisol, MPA, progesterone 
and NET had PR expression levels that significantly lower than the MPA levels in the BCG 
induced stimulations. Day 3 post stimulation with BCG revealed no statistically significant 
differences in the expression levels of PR (figure 3.16d). Post stimulation with BCG on day 6 
the addition of cortisol to BCG had PR expression levels that were significantly lower than 
was seen for the addition of MPA, progesterone and NET to BCG stimulation. The addition 
of cortisol to BCG had significantly lower PR expression than the hormone only groups as 
well namely cortisol, MPA, progesterone and NET (figure 3.16f).  
The progesterone only group had increased PR expression the in anti-CD3 stimulations. From 
the BCG stimulations the addition of MPA and progesterone increased the PR expression, 
whereas the addition of cortisol to BCG inhibited the expression levels of PR in the cells. 
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Figure 3.16: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced PR 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate.The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
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iii. AR 
 
The AR expression for the anti-CD3 day 1 stimulations revealed no statistically significant 
results (figure 3.17a). Day 3 post stimulation the MPA only stimulation had significantly 
higher AR expression when compared to the addition of the hormones cortisol, MPA, 
progesterone, NET to anti-CD3 stimulation, as well as the cortisol only stimulation (figure 
3.17c). The stimulation with progesterone only had significantly higher AR expression when 
compared to the addition of progesterone to the anti-CD3 stimulation. The addition of MPA, 
progesterone and NET to anti-CD3 stimulation produced significantly lower AR expression 
levels in comparison with NET only. The cortisol only stimulation had significantly higher 
expression levels of AR when compared to the anti-CD3 induced progesterone receptor 
expression and the NET only stimulation. Day 6 (figure 3.17e) the cortisol only stimulation 
had significantly higher AR expression levels when compared to the anti-CD3 stimulated 
progesterone treated cells, and the NET only treated cells.  
 
On day 1 post stimulation for BCG the addition of cortisol to BCG and the progesterone only  
and NET only stimulations have significantly higher expression levels of AR when compared 
to the stimulations where MPA, progesterone and NET where added to the BCG stimulation, 
as well as the cortisol, MPA and NET only stimulations (figure 3.17a). Day 3 post BCG 
stimulation the addition of cortisol and MPA to BCG stimulations expressed significantly 
higher AR levels when compared to the addition of progesterone and NET to BCG 
stimulation, as well as the cortisol, MPA, progesterone and NET only stimulations (figure 
3.17c). The BCG day 6 stimulations reveal that the addition of progesterone to BCG had a 
significantly higher AR expression level when compared to the addition of cortisol to the 
BCG stimulation as well the cortisol only stimulation (figure 3.17e). 
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Figure 3.17: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced AR 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
iv. mPR-α 
 
For the day 1 anti-CD3 stimulations the progesterone only stimulation had significantly 
higher mPR-α expression levels when compared to the addition of cortisol, MPA, 
progesterone and NET to the anti-CD3 stimulations as well as MPA only stimulation (figure 
3.18a). On day 3 post stimulation the MPA only stimulation had mPR-α expression levels 
that were significantly higher than the expression levels of the anti-CD3 stimulations where 
cortisol, MPA, progesterone and NET were added (figure 3.18c). At day 6 post stimulation 
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the progesterone only stimulation had mPR-α expression levels that were significantly higher 
than the stimulations where MPA and NET was added to anti-CD3 (figure 3.18e).  
Day 1 the changes in mPR-α expression levels for BCG stimulations with the addition of 
MPA showed significantly higher mPR-α expression levels when compared to the addition of 
cortisol, progesterone and NET to BCG stimulated cells as well as the cortisol, MPA, 
progesterone and NET only stimulations (figure 3.18b). The addition of cortisol to the BCG 
stimulated cells had significantly lower mPR-α expression levels when compared to the 
addition of progesterone to BCG stimulated cells as well as the cortisol and progesterone only 
stimulations. The BCG stimulated cells on day 3 post stimulation showed that the addition of 
MPA had significantly higher mPR-α expression when compared to the addition of cortisol 
and NET to BCG stimulations (figure 3.18d). On day 6 post stimulation the addition of MPA 
expressed significantly higher mPR-α in the cells in comparison with the cortisol only 
stimulation (figure 3.18f). 
The additions of MPA and progesterone only stimulations lead to an increase in the mPR-α 
expression levels in the PBMCs.  The addition of MPA and progesterone led to an increase in 
the BCG induced mPR-α expression.  
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Figure 3.18: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced mPR-α 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b and c indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
v. mPR-β 
 
At day 1 post stimulation the differences observed in the anti-CD3 stimulations did not reach 
a level of statistical differences for any of the stimulations (figure 3.19a). For the stimulations 
at day 3 the mPR-β expression levels of the cortisol only stimulation had significantly higher 
expression levels in comparison with the anti-CD3 stimulations were cortisol, MPA, 
progesterone and NET was added to the stimulation along with the MPA, progesterone and 
NET only stimulations (figure 3.19c). Day 6 post stimulation with anti-CD3 showed that the 
MPA only stimulation expressed significantly higher levels of mPR-β when compared to 
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anti-CD3 stimulations with the addition of the hormones cortisol, MPA, progesterone and 
NET including the cortisol only stimulation (figure 3.19e).  
From the day 1 BCG stimulations addition of MPA to the BCG stimulation had significantly 
increased the mPR-β expression when compared to the BCG stimulation where cortisol, 
MPA and NET were added to the stimulations, together with the cortisol, MPA, progesterone 
and NET only stimulations (figure 3.19b). On day 3 the addition of progesterone to the BCG 
stimulation had significantly higher mPR-β expression levels when compared to addition of 
cortisol to the BCG stimulation (figure 3.19d). On day 6 stimulations show that the addition 
of MPA to the BCG stimulation expressed significantly higher mPR-β levels when compared 
to the addition of cortisol and NET to the BCG stimulation as well as the cortisol only 
stimulation (figure 3.19f). 
 The addition of MPA and progesterone to BCG stimulated cells resulted in an increase in the 
expression levels of the mPR-β. This was also seen in the MPA and progesterone only 
stimulations in the anti-CD3 stimulated cells.   
 
Stellenbosch University  http://scholar.sun.ac.za
88 
 
 
Figure 3.19: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced mPR-β 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b and c indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
vi. mPR-γ 
 
On day 1 MPA significantly increased anti-CD3 mediated mPR-γ expression in comparison 
with the addition of cortisol to the anti-CD3 stimulation along with the cortisol only 
stimulation (figure 3.20a). The MPA, progesterone and NET only stimulations expressed 
significantly higher mPR-γ levels when compared to the anti-CD3 induced MPA expression 
levels. On day 3 the observed changes in mPR-γ expression levels did not reach a level of 
statistical significance (figure 3.20c). On day 6 the MPA and progesterone only stimulations 
had significantly higher anti-CD3 mediated mPR-γ expression levels when compared the 
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anti-CD3 mediated expression for cortisol, MPA, progesterone and NET,  as well as the 
cortisol and NET only stimulations (figure 3.20e). 
On day 1 the addition of cortisol to the BCG stimulations expressed significantly lower mPR-
γ compared to the BCG induced MPA and progesterone expression and MPA only expression 
levels. The MPA expressed significantly higher BCG induced mPR-γ levels when compared 
to BCG induced expression levels for cortisol and NET, along with the hormone only 
cortisol, MPA, progesterone and NET stimulations (figure 3.20b). On day 3 no statistically 
significant differences were observed (figure 3.20d). On day 6 the addition of MPA to the 
BCG stimulation expressed significantly higher mPR-γ in comparison with the addition of 
cortisol and NET to the BCG stimulations as well as the cortisol only stimulation (figure 
3.20f).  
The addition of MPA and progesterone to BCG stimulated cells, including the hormone only 
stimulations of MPA and progesterone increased the mPR-γ expression levels of the cells. 
The increase in mPR-γ expression level was not seen with the addition of cortisol to BCG s 
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Figure 3.20: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced mPR-γ 
expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
vii. PGRMC1 
 
On day 1 there were no statistically different observations for the anti-CD3 stimulations 
(figure 3.21a). On day 3 the progesterone only stimulation had significantly higher PGRMC1 
expression when compared to the anti-CD3 mediated expression of cortisol, MPA, 
progesterone and NET along with the cortisol only stimulation (figure 3.21c). The MPA and 
NET only stimulations had significantly higher PGRMC1 expression levels when compared 
to the anti-CD3 mediated expression for cortisol, MPA and NET. On day 6 the cortisol only 
stimulation had significantly higher PGRMC1 expression levels when compared to the anti-
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CD3 induced MPA, anti-CD3 induced progesterone and NET only PGRMC1 expression 
(figure 3.21e).  
On day 1 the addition of MPA to the BCG stimulation had significantly higher PGRMC1 
expression when compared to the BCG mediated cortisol and progesterone expression levels 
(figure 3.21b). On day 3 there were no statistically significant differences for the BCG 
stimulations (figure 3.21d). On day 6 the addition of progesterone to the BCG stimulations 
had significantly higher PGRMC1 expression levels in comparison with the BCG mediated 
expression levels of cortisol and  NET, including the cortisol, MPA and progesterone only 
stimulations (figure 3.21f). 
The addition of the hormones, cortisol, MPA and progesterone to anti-CD3 and BCG 
stimulations led to the increased expression levels of PGRMC1. This was also seen in the 
MPA and progesterone only stimulations. 
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Figure 3.21: The effect of cortisol, MPA, progesterone and NET on BCG and anti-CD3-induced 
PGRMC1 expression. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
receptor expression was measured in the cell lysates harvested on day 3 and 6 post stimulation, using real time 
RT-PCR based on the expression of GAPDH. n=2 for all stimulations within the panel. With all experiments 
performed in triplicate. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicates statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
Summary: 
 
The receptors were detectable at mRNA level thus suggesting that they could be expressed at 
protein level to potentially interact with the hormones when introduced to the cells. The 
addition of the hormones MPA and progesterone to the cells increased the expression levels 
of the GR, AR, mPR-α, mPR-β, mPR-γ and PGRMC1, for the membrane receptors and 
PGRMC1 this occurred for both the anti-CD3 and BCG mediated expression. The expression 
levels of the PR were increased by the presence of progesterone only in both anti-CD3 and 
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BCG. The addition of MPA to the BCG stimulations increased the mRNA expression of PR. 
In the anti-CD3 mediated expression of the AR the presence of NET increased the expression 
of AR, this was also seen in the NET only stimulation.  
The limitation of the RT-PCR receptor expression experiments was that the same patients 
were not used for the anti-CD3 and BCG stimulations, thus inter-patient variability could 
affect the results. It would be more preferable to isolate PBMCs from the same patients for 
both the stimulation assays, anti-CD3 and BCG, to minimize the effect that patient variability 
would have. Thus a direct comparison can be drawn between the stimulatory conditions.  
3.6 BCG and anti-CD3 induced activation of signalling molecules in 
human PBMCs  
 
The aim of this investigation was to determine what signalling molecules are affected by the 
BCG and anti-CD3 stimulations. Over and above what the addition of the hormone will be on 
the signalling molecules. To meet these aim three different techniques were used: 
a) A phospho-kinase array kit, which determines protein levels. 
b) Western blot for the total and phosphorylated protein for the following kinases p38, 
JNK and ERK 1/2. 
c) Luminex technology that determines phosphoprotein levels for CD3ε, Lck, LAT, 
ZAP-70, ERK 1/2, CREB, STAT5, p38, JNK, IκBα, p70S6 and STAT3. 
3.6.1 Human Phospho-kinase array in stimulated PBMCs 
 
The human phospho-kinase array is based on the principles of Western blot technology. The 
following signalling molecules were measured in the PBMC lysates within the array: p38α, 
ERK 1/2, JNK 1/2/3, GSK-3α/β, p53, EGF R, MSK 1/2, AMPKα1, Akt 1/2/3, TOR, CREB, 
HSP27, AMPKα2, β-catenin, p70S6, c-Jun, Src, Lyn, Lck, STAT2, STAT 5A/B, RSK 1/2/3, 
eNOS, Fyn, Fgr, STAT6, STAT 5b, STAT 3, p27, PLC-γ1, Hck, Chk-2, FAK, PDGF Rβ, 
WINK1, PYK2 and Hsp60. Each of the dots represents a kinase in duplicate.  Each of the 
stimulations is run on two blots, blot A and blot B, as can be seen in figure 3.23. The two 
spots on the periphery of the blots indicated by the white blocks are the positive controls and 
used to orientate the blots so the kinases can be identified during analysis.  Although 
differences can be visually attained from the blots, the Unscan-it software was not sensitive 
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enough to quantify the dots, due to the small size of the dots on the blot and a lot of 
background was included in the pixel density value generated by the software. 
 
Figure 3.22: Four stimulation conditions were analysed using the Human Phospho-Kinase array a) BCG, 
b) BCG + cort, c) BCG + MPA and d) BCG + Prog.  
Blots were blocked in buffer provided. Stimulated 1x 10
6
 PBMC cell lysates were incubated overnight with 
blots. Next day incubation with detection antibody cocktail and streptavidin-HRP enzymes. Blots were 
visualized by treatment with chemiluminescent reagents followed by exposure to light-sensitive film.  
 
As the Human Phospho-Kinase array technique was not sensitive enough to meet our aim of 
determining the differences in signalling molecules under different stimulations with the 
addition of hormones. Normal Western blot antibodies were acquired, to generate 
quantifiable data. 
3.6.2 Kinase expression in stimulated PBMCs 
 
The aim was to determine alterations in the expression of the kinases after stimulation with 
hormones. The active phospho-protein state as well as total expression of ERK 1/2, JNK and 
p38 was looked at within in cell lysates of PBMCs. Once a kinase becomes phosphorylated it 
becomes activated and can interact with downstream signalling molecules. When the 
phosphate is removed from the kinase, it returns to its inactive state.  
a) BCG b) BCG + cort c) BCG +MPA d) BCG + prog 
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The phosho-protein antibody was used to detect the amount of active kinase in PBMCs, 
which would then be compared to and normalised to the total amount of kinase protein within 
the cells. The same blot was first probed with the phosho-protein antibody, prior to being 
stripped and re-blotted with the total protein antibody. The phoso-protein was first blotted, so 
that any residual signal that remains after the stripping process will not affect the blot to such 
an extent as it would have been included in the total protein. 
i. p38 
 
The Western blot gels were quantified using software to assign pixel density values to the 
individual lanes on the blot. The graphs are depicted as the pixel density values generated 
from the phospho-protein where normalized against the total protein pixel density values. 
From the p38 Western blot data (figure 3.23A, B) it can be seen that the addition of cortisol 
to BCG led to a reduction in the phosphorylation of the p38 kinase (figure 3.23B). The 
addition of progesterone did not inhibit the BCG induced phosphorylation of p38, but 
increased the phosphorylation of the p38 kinase. 
 
Figure 3.23:Western Blot representing the banding pattern of p38 a) phospho- and b) total protein in 
PBMC cells.  
A) 20µg Stimulated PBMC cell lysates were subjected to SDS-PAGE and proteins transferred to hybond ECL 
membranes. Blot probed with a 1:1000 of the p38-reactive monoclonal antibody for phosphor- and total protein. 
Followed by incubation with 1:5000 of the Rabbit IgG HRP-linked secondary antibody. Blots were visualized 
by treatment with chemiluminescent reagents followed by exposure to light-sensitive film. Samples yielded a 
single prominent band at approximately 40 kDa. The data is representative of 2 independent experiments. B) A 
pixel density percentage value was assigned to the individual lanes in the Western blots using UN-SCAN-IT 
software. Graph shows the pixel density for the phosphor-protein blot divided by the total protein blot. 
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ii. JNK 
 
From the Western blot data (figure 3.24A, B) the addition of MPA and NET increased the 
BCG induced phosphorylation of JNK.  Whereas the BCG infected state and BCG induced 
cortisol levels JNK phosphorylation levels were lowered. 
 
Figure 3.24: Western Blot representing the banding pattern of JNK a) phospho- and b) total protein in 
PBMC cells. 
A) 20µg Stimulated PBMC cell lysates were subjected to SDS-PAGE and proteins transferred to hybond ECL 
membranes. Blot probed with a 1:1000 of the JNK-reactive monoclonal antibody for phosphor- and total 
protein. Followed by incubation with 1:5000 of the Rabbit IgG HRP-linked secondary antibody. Blots were 
visualized by treatment with chemiluminescent reagents followed by exposure to light-sensitive film. Samples 
yielded a single prominent band at approximately 46 kDa. The data is representative of 2 independent 
experiments. B) A pixel density percentage value was assigned to the individual lanes in the Western blots using 
UN-SCAN-IT software. Graph shows the pixel density for the phosphor-protein blot divided by the total protein 
blot. 
 
iii. ERK 1/2 
 
The Western blot data (figure 3.25A, B) shows that the addition of cortisol and MPA, 
increases the BCG induced phosphorylation of ERK 1/2. The total protein blot displays low 
levels of protein, this could possibly be attributed to the procedure used to strip the blot.  
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Figure 3.25: Western Blot representing the banding pattern of ERK 1/2 a) phospho- and b) total protein 
in PBMC cells. 
A) 20µg Stimulated PBMC cell lysates were subjected to SDS-PAGE and proteins transferred to hybond ECL 
membranes. Blot probed with a 1:1000 of the ERK 1/2-reactive monoclonal antibody for phosphor- and total 
protein. Followed by incubation with 1:5000 of the Rabbit IgG HRP-linked secondary antibody. Blots were 
visualized by treatment with chemiluminescent reagents followed by exposure to light-sensitive film. Samples 
yielded a single prominent band at approximately 44 kDa. The data is representative of 2 independent 
experiments. B) A pixel density percentage value was assigned to the individual lanes in the Western blots using 
UN-SCAN-IT software. Graph shows the pixel density for the phosphor-protein blot divided by the total protein 
blot. 
 
The Western blot kinase blots will not be able to detect subtle changes in kinase 
phosphorylation. There is also the possibility that in the stripping protocol some of the 
protein can be stripped off of the blot, or that the antibodies are not properly stripped and the 
total protein blot then gives a false representation of the amount of protein present. To meet 
the aims of determining the difference between signalling molecules with the addition of 
different hormones to anti-CD3 and BCG, a more sensitive method of detection is required. 
The introduction of a BCG infection in the PBMCs will induce an antigen specific response, 
with potential co-receptor activation and the activation of several signalling cascades. 
Stimulation with anti-CD3 will induce a non-specific response, which directs TCR activation 
and signalling without co-receptor activation. The Luminex technology was selected as it is a 
very sensitive technique and therefore will be able to detect subtle changes within the 
signalling molecules under the different stimulations. The added advantage of this technique 
is that multiple analytes can be tested per sample thus making direct comparison of 
stimulations possible. The kits that we selected for the two sections below describe the 
signally molecules of the non-specific TCR signalling (3.4.3), and a broader range of kinases 
and transcription factors that form part of multiple signalling cascades (3.4.4). 
3.6.3 The effect of the hormone cortisol, MPA, progesterone and NET on 
BCG and anti-CD3 induced TCR signalling in human PBMCs 
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3.6.3.1 Anti-CD3- and anti-CD3+CD28-induced activation of kinases 
 
To determine whether the kit was able to detect changes in TCR signalling within our sample 
cohort, a positive control sample was run on the kit. PBMCs from a patient were stimulated 
with anti-CD3, known to activate T-cell activation, as well as anti-CD3 with anti-CD28, 
known for its activation and proliferation of T-cells, the addition of CD28 amplifies the 
signal transduction. In both the anti-CD3 and anti-CD3 + anti-CD28 stimulations a very high 
level of Lck was detected. The high detectable levels of Lck and downstream, signalling 
molecule CREB, shows that the TCR was indeed activated, Lck is activated upon TCR 
activation and then leads to the activation of downstream signalling molecules. In the US 
sample there are high Lck present, but the downstream molecules where not phosphorylated.  
 
Figure 3.26: Mean Fluorescent Intensity (MFI) of the different kinases in the PBMCs. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with 1µg/ml anti-CD3 or anti-CD3+anti-CD28 
respectively. The concentration of the phosphorylation of  the kinases was measured with a 7-plex Luminex 
panel. The data was presented as mean ± SEM. (n=1, in duplicate). 
 
The fact that detectable levels for all the kinases were found with the kit it was deemed to be 
a suitable for our research purposes. Although both the anti-CD3 and anti-CD3 + anti-CD28 
could be used for T-cell activation, the anti-CD3 was chosen for further experiments as the 
anti-CD3 + anti-CD28 has the ability to activate more than one pathway through co-
activation, thus in order to try and minimize the activation of numerous signalling pathways 
anti-CD3 was used as a stimulant.  
To determine the effect that the hormones, cortisol, progesterone, MPA and NET would have 
on the signalling pathways after stimulation with BCG and anti-CD3 respectively, multiplex 
bead array assays were used to assess the phoshoprotein signalling molecule production from 
PBMCs isolated from whole blood samples of woman not currently receiving any steroid 
treatment or using any hormone based contraception method. The Luminex panels revealed 
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that alterations occurred in the phosphoprotein profiles of the different signalling molecules 
under the different stimulatory conditions. 
3.6.3.2 Observations made on day 1 post anti-CD3 stimulation. 
 
The T-cell signalling was looked at when PBMCs were stimulated with anti-CD3 antibody 
which is a known T-cell activator under different stimulatory conditions in the presence or 
absence of hormones (Cortisol, Progesterone, MPA and NET). 
Identical samples were run on both the 7-plex and 8-plex Luminex panels, the sample aliquot 
was thawed once and loaded onto the two plates respectively.  
The inclusion of day 1 in the anti-CD3 stimulation panel acted as a screening tool to see 
whether differences were observed in kinase activation under the different stimulations, and 
whether further investigation could be considered. Usually kinase activation is rapid within 
minutes. However, our time points were used to co-inside with the cytokine data collection 
time points. The supernatants form the cells were used for cytokine determination. Thus the 
possibility of detecting the early effects is negligible, but the genomic effects could be 
detected.  
There were no statistically significant changes observed in the day 1 anti-CD3 stimulations. 
The time points, day 3 and day 6, were included to determine whether the changes in kinase 
activation were only detectable at the later time points.  
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3.6.3.3 Observations made on day 3 and day 6 post BCG and anti-CD3 stimulation. 
 
i. CD3ε 
 
On day 3 (figure 3.27b) the addition of cortisol, MPA, progesterone and NET to BCG 
stimulations showed a decrease in phosphorylated CD3ε levels. On day 6 the addition of 
cortisol, MPA, progesterone and NET to BCG stimulations showed an increase in 
phosphorylated CD3ε (figure 3.27d).  
 
ERK 1/2 LAT Lck 
CREB ZAP-70 CD3ε 
Syk 
Figure 3.26: The effect of cortisol, MPA, progesterone and NET within anti-CD3-induced responses 
on TCR signalling a) ERK 1/2, b) LAT, c) Lck, d) ZAP70, e) CD3ε, f) CREB and g) Syk 
phoshoprotein levels on day 1 post stimulation. 
 PBMCs (1x10
6
cells/well) were cultured and stimulated with 1µg/ml anti-CD3 respectively, in the 
presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The kinase 
expression was measured in the cell lysates harvested on day 1 post stimulation, via a 7-plex TCR 
Luminex panel. US, anti-CD3 and anti-anti-CD3 + all four hormones, n=2. Cortisol, MPA, progesterone 
and NET, n=1. All experiments were run in duplicate. The data was analyzed using a one-way ANOVA 
with a Fisher LSD post hoc test and presented as least-squares means and 95% confidence intervals. The 
letter a indicates statistical significance, where values with the same letter are not significantly different 
from each other.  A P value of 0.05 was regarded as significantly different. 
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Six days post stimulation with anti-CD3 revealed that NET had significantly lower anti-CD3 
induced levels of phosphorylated CD3ε (figure 3.27c). MPA stimulation had significantly 
higher anti-CD3 induced CD3ε phosphorylation levels when compared to cortisol and NET 
stimulations.  
 
Figure 3.27: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on CD3ε 
phosphorylation levels.   
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
ii. Lck 
 
On day 3 for anti-CD3 stimulation (figure 3.28a) the addition of cortisol shows a decrease in 
detectable levels, though not significant, of phosphorylated Lck. Cortisol only stimulation 
produced Lck levels that were significantly lower than the anti-CD3 induced cortisol, MPA, 
progesterone and NET stimulations Lck levels. On day 6 with anti-CD3 (figure 3.28c) it can 
be seen that the anti-CD3 induced stimulation decreased the level of Lck phosphorylation 
significantly for cortisol, MPA, progesterone, NET, as well as cortisol only, MPA only, 
progesterone only  and NET only stimulations. Cortisol, MPA and progesterone only 
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stimulations have significantly lower phosphorylated Lck levels when compared to the anti-
CD3 induced MPA and progesterone Lck levels. 
 
On day 3 (figure 3.28b) there was a decrease in Lck phosphorylation levels of the BCG 
induced cortisol and MPA levels, however the difference did not reach a level of significance. 
The phosphorylation of Lck in progesterone and NET in BCG stimulated cells, were higher 
than the Lck level displayed by the BCG induced Lck phosphorylation in cortisol and MPA 
stimulated cells.  
On day 6 (figure 3.28d) the progesterone only stimulation had significantly lower Lck 
phosphorylation than NET only.  
 
Figure 3.28: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on Lck 
phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
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iii. ZAP-70 
 
Day 3 (figure 3.29a) revealed no changes that reached a level of statistical significance. On 
day 6 (figure 3.29c) the anti-CD3 induced NET stimulation showed lower levels of 
phosphorylated ZAP-70, although not statistically significant. 
 
On day 3 (figure 3.29b) no observations reached a level of statistical significance. The BCG 
stimulated cells had significantly lower levels of phosphorylated ZAP-70 when compared to 
the BCG infected cells treated with NET stimulation levels. On day 6 (figure 3.29d) the 
changes in ZAP-70 levels did not reach significant levels for any of the observations made at 
day 6 post stimulation.  
 
 
Figure 3.29: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
ZAP70 phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
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iv. LAT 
 
On day 3 (figure 3.30a) the anti-CD3 induced levels of phosphorylated LAT were decreased 
by cortisol, MPA, progesterone and NET, a level of statistical significance was only observed 
for anti-CD3 induced cortisol and NET stimulations. The anti-CD3 stimulated cells treated 
with cortisol and NET had lower levels of LAT phosphorylation when compared to anti-CD3 
stimulated MPA and progesterone treated cells. In the hormone only stimulated groups, 
progesterone treated cells had higher levels of phosphorylated LAT compared to cortisol, 
MPA and NET stimulations. On day 6 (figure 3.30c) the anti-CD3 induced levels of LAT 
phosphorylation where higher than the cortisol, MPA and NET treated cells.  
 
On day 3 (figure 3.30b) the BCG stimulated cells decreased the phosphorylated LAT levels 
when compared to cortisol, MPA and progesterone treated cells. However from the hormone 
treated cells, only the BCG induced lowering of cortisol LAT levels were significantly lower. 
On day 6 (figure 3.30d) the addition of MPA to BCG stimulation showed higher levels of 
LAT phosphorylation when compared to the addition of cortisol, progesterone and NET to 
BCG stimulations. The BCG induced cortisol LAT phosphorylation level was lower than the 
BCG induced MPA, progesterone and NET phosphorylated LAT levels. However, none of 
the observed differences reached a level of statistical significance. 
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Figure 3.30: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on LAT 
phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
v. CREB 
 
Day 3 (figure 3.31a) shows the detectable levels of phosphorylated CREB are decreased in 
anti-CD3 stimulated cells in the cortisol, MPA, progesterone and NET treated cells. Only 
anti-CD3 stimulated induced phosphorylation of CREB in NET treated cells reached 
significant difference. The anti-CD3 induced CREB phosphorylation levels of cells treated 
with cortisol and progesterone were increased in comparison with the CREB phosphorylation 
induced by anti-CD3 in cells treated with MPA. The anti-CD3 induced NET phosphorylated 
CREB levels were inhibited when compared to anti-CD3 induced levels of cells treated with 
cortisol, MPA and progesterone. On day 6 (figure 3.31c) none of the observations reached a 
level of statistical significance. 
On day 3 and day 6 (figure 3.31b, d) the BCG stimulations showed very low levels of 
detectable phosphorylated CREB. The range of MFI detected for CREB did not exceed 100. 
This equals one tenth of the detectable range achieved by the anti-CD3 stimulations, which 
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had a detectable range reaching 1000 MFI. This occurrence of BCG failing to activate CREB 
can also be seen in the 8-plex Multiple signalling panel CREB graph shown in figure 3.39b, 
d. 
 
Figure 3.31: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
CREB phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
vi. ERK/MAP kinase 1/2 
 
On day 3 (figure 3.32a) the level of phosphorylated ERK 1/2 is increased in the anti-CD3 
stimulated cells treated with cortisol compared to the anti-CD3 induced, MPA, progesterone 
and NET treated. This however, does not reach a level of statistical significance. The addition 
of NET, to anti-CD3 stimulated cells decreased the levels of ERK 1/2 phosphorylation when 
compared to the addition of cortisol, MPA and progesterone. On day 6 (figure 3.32c) 
ERK/MAP kinase 1/2 of anti-CD3 stimulated cells. The anti-CD3 induced NET ERK 1/2 
levels showed the highest inhibition of phosphorylated ERK 1/2 when compared to the anti-
anti-CD3 induced levels of cortisol, MPA, and progesterone stimulations. With the anti-CD3 
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induced level of ERK 1/2 for NET being significantly lower than the anti-CD3 induced levels 
of MPA and progesterone stimulations.  
 
No observations of statistical significance were reached for the day 3 (figure 3.32b) nor day 6 
(figure 3.32d) for the BCG stimulations.  
 
Figure 3.32: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on ERK 
1/2 phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
vii. SYK 
 
On day 3 (figure 3.33a) anti-CD3 induced level of phosphorylated Syk in cortisol treated 
cells had significantly higher levels when compared MPA, progesterone and NET treated 
cells. The addition of NET to CD3 stimulation displayed significantly lower levels of 
phosphorylated Syk in comparison with the addition of cortisol, MPA and progesterone to 
anti-CD3 stimulations. On day 6 (figure 3.33c) the addition of cortisol to anti-CD3 
stimulations produced significantly higher Syk phosphorylation levels when compared to the 
addition of progesterone, and NET stimulations. The addition of MPA, progesterone and 
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NET to anti-CD3 stimulations led to the inhibition of phosphorylated Syk levels however the 
differences are not statistically significant.  
 
There were no statistically significant differences observed for the day 3 time point (figure 
3.33b), for any of the stimulations within the BCG panel. On day 6 (figure 3.33d) the addition 
of cortisol, MPA, progesterone and NET to BG stimulations had increased the 
phosphorylated Syk levels.  
 
Figure 3.33: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on Syk 
phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 7-plex 
TCR Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and 
presented as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical 
significance, where values with the same letter are not significantly different from each other.  A P value of 0.05 
was regarded as significantly different. 
 
Summary: 
 
The addition of the anti-CD3 stimulus led to an increase in phosphorylation from basal levels 
in the following signalling molecules CD3ε, Lck, ZAP-70, LAT, CREB and Syk. The 
introduction of BCG infection led to a decrease in phosphorylation of the early TCR 
signalling molecules namely CD3ε and Lck. The addition of cortisol to the stimulations led to 
the inhibition of phosphorylation on certain kinases, Lck, ZAP-70, LAT, ERK 1/2. The 
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addition of cortisol, MPA, progesterone and NET caused the inhibition of anti-CD3 induced 
phosphorylation of the transcription factor CREB. The addition of MPA, progesterone and 
NET in stimulations caused the inhibition of ERK 1/2 phosphorylation. Thus for the 
signalling molecules it cannot be clearly determined whether the hormones MPA and NET 
mimic cortisol or progesterone as they shift between exhibiting protestogenic and 
glucocorticoid activity.  
3.6.4 The effect of the hormones cortisol, MPA, progesterone and NET on 
BCG and anti-CD3 induced signalling pathways in PBMCs 
 
The beads in the Luminex kit used to analyse the signalling pathways, detects the changes in 
phosphorylated p70S6 at threonine 412, phosphorylated STAT5A/B at tyrosine 694 and 699, 
STAT3 at serine 727, phosphorylated p38 MAP kinase at threonine 180 and tyrosine 182 and 
JNK at threonine 183 and tyrosine 185. The bead used to detect the changes in the 
phosphorylated IκBα at serine 32.  
3.6.4.1 Observations made on day 1 post anti-CD3 stimulation. 
 
The changes in the phosphoprotein expression of numerous cell signalling molecules are 
depicted in figure 3.34 (a-h), these kinases do not belong to a singular pathway but can play a 
role in different signalling cascades.  
The changes in ERK 1/2 (figure 3.34a), no levels of significant differences were observed for 
the day 1 time point.  
No differences were observed for STAT3 (figure 3.34b). 
The changes in the level of JNK expression (figure 3.34c), was suppressed by cortisol in the 
anti-CD3 stimulated cells. MPA and NET stimulated cells had no inhibitory effect on the 
production of JNK when compared to cortisol treated cells. Progesterone treated cells had no 
effect on the anti-CD3 induced JNK phosphorylation.  
Cortisol treated cells produced significantly lower levels of p70S6 (figure 3.34d) when 
compared to the anti-CD3 induced responses of the MPA and NET treated cells. The MPA 
and NET only stimulated cells produced more p70S6 than the cortisol and progesterone only 
stimulated cells.  
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The IκBα levels for the anti-CD3 induced stimulations (figure 3.34e) produced more IκBα 
than was produced by the four hormone only stimulations. None of the observed differences 
reached a level of significant difference. 
The changes in STAT5A/B levels (figure 3.34f), the treatment of cells with cortisol inhibited 
the anti-CD3 induced production of STAT5A/B. MPA, progesterone and NET enhanced the 
anti-CD3 induced production of STAT5A/B when compared to the suppressive effect of 
cortisol. All four hormone only treated cells produced significantly lower levels of 
STAT5A/B in comparison with anti-CD3 stimulated cells. Stimulation with anti-CD3 in cells 
results in the activation of STAT5A/B.  
No changes in the phosphorylation of CREB was seen at day 1 (figure 3.34g). 
Cortisol suppressed the anti-CD3 induced phosphorylation of p38 (figure 3.34h). In the anti-
CD3 stimulated cells the cortisol treatment had a greater suppressive effect when compared 
to the inhibition levels of MPA, progesterone and NET treated cells. Cortisol only had 
significantly lower p38 than all the anti-CD3 stimulated cells with hormone treatment.  
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Figure 3.34: The effect of cortisol, MPA, progesterone and NET on anti-CD3-induced on a) ERK 1/2, b) 
STAT3, c) JNK, d) p70S6, e) IκBα, f) STAT5A/B, g) CREB and h) p38 MAP kinase phosphorylation on 
day 1 post stimulation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with 1µg/ml anti-CD3 respectively, in the presence and 
absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The kinase expression was measured 
in the cell lysates harvested on day 1 post stimulation, via a 7-plex TCR Luminex panel. The data was analyzed 
using a one-way ANOVA with a Fisher LSD post hoc test and presented as least-squares means and 95% 
confidence intervals. The letters a, b and c indicate statistical significance, where values with the same letter are 
not significantly different from each other.  A P value of 0.05 was regarded as significantly different. 
 
3.6.4.2 Observations made on day 3 and day 6 post BCG and anti-CD3 stimulation. 
i. STAT5A/B 
 
Day 3 (figure 3.35a) cortisol and MPA enhanced the anti-CD3 induced phosphorylation of 
STAT5A/B, however the progesterone and NET exhibited a suppressive effect on the 
STAT5A/B phosphorylation levels. Day 6 did not display a noticeable change between the 
different stimulatory conditions (figure 3.35c). 
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Day 3 (figure 3.35b) showed that cortisol, MPA, progesterone and NET significantly 
inhibited the BCG induced phosphorylated STAT5A/B levels. On day 6 (figure 3.35d) the 
BCG induced stimulation shows a significantly higher STAT5A/B level was produced when 
compared to cortisol, MPA and progesterone only stimulations.  
 
Figure 3.35: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
STAT5A/B phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b and c indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
ii. ERK/MAPK 1/2  
 
On day 3 (figure 3.36a), cortisol treatment enhanced the phosphorylation of ERK 1/2 in anti-
CD3 stimulated cells. The NET treated cells significantly inhibited the phosphorylation of 
ERK 1/2 compared to MPA and progesterone treated anti-CD3 stimulated cells. On day 6 
(figure 3.36c), cortisol treatment enhanced the phosphorylation of ERK 1/2 in anti-CD3 
stimulated cells. MPA treated cells had significantly lower in the phosphorylated ERK 1/2 
when compared to the cortisol treated anti-CD3 stimulated cells.  
Day 3 (figure 3.36b) no statistically significant differences were observed. 
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On day 6 (figure 3.36d), cortisol, MPA, progesterone and NET treatment suppressed the 
phosphorylation of ERK 1/2 in BCG stimulated cells. The cortisol only stimulation produced 
significantly lower levels of phosphorylated ERK 1/2 when compared to the BCG induced 
effect on cortisol, progesterone, NET and progesterone only stimulations.  
 
Figure 3. 36: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on ERK 
1/2  phosphorylation.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
iii. p70S6 kinase 
 
On day 3 (figure 3.37a), cortisol treatment enhanced the anti-CD3 mediated production of 
phosphorylated p70S6 levels in comparison with the effect of MPA and progesterone. The 
addition of NET to anti-CD3 stimulated cells enhanced the phosphorylation of p70S6 
production, when compared to the inhibitory effect of cortisol, MPA and progesterone treated 
cells. Cortisol only had a significantly higher level of p70S6 when compared to all the other 
stimulatory conditions. On day 6 (figure 3.37c), MPA stimulation had significantly higher 
levels of phosphorylated p70S6 when compared all the other stimulatory conditions. Cortisol 
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treatment significantly enhanced the anti-CD3 induced p70S6 phosphorylation levels when 
compared to the anti-CD3 stimulated MPA treated cells.  
On day 3 (figure 3.37b) stimulations for BCG had no distinguishable pattern and failed to 
reach any significant differences. On day 6 (figure 3.37d) BCG stimulated cells had 
significantly higher levels of phosphorylated p70S6 when compared to the cortisol, MPA, 
progesterone and NET only stimulations.  
 
Figure 3.37: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
p70S6 phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
iv. STAT3 
 
Day 3 (figure 3.38a) post anti-CD3 stimulation there was no difference among any of the 
conditions. On day 6 (figure 3.38c), the treatment of anti-CD3 stimulated cells with cortisol, 
MPA, progesterone and NET significantly inhibited the phosphorylation of STAT3.  
On day 3 (figure 3.38b) post BCG stimulation no distinct pattern could be identified for the 
different stimulatory conditions and none reached a level of significance. Day 6 (figure 
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3.38d) the BCG stimulated cells treated with cortisol, MPA, progesterone and NET had lower 
detectable levels of phosphorylated STAT3.  
 
Figure 3.38: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
STAT3 phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b and c indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
v. CREB 
 
On day 3 (figure 3.39a) no levels of statistically significance levels were observed. Day 6 
(figure 3.39c) the phosphorylation of CREB in the anti-CD3 stimulated cells was 
significantly inhibited by MPA treatment. The inhibition of MPA treatment on the anti-CD3 
stimulated phosphorylation of CREB was significantly lower than in the cortisol, 
progesterone and NET treated cells. 
Day 6 (figure 3.39d) the BCG stimulated cells had significantly higher CREB 
phosphorylation than the other stimulatory conditions, except for the MPA and progesterone 
treated BCG stimulated cells.  
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Figure 3.39: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on 
CREB phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
vi. p38 MAP kinase 
 
Day 3 (figure 3.40 a) the anti-CD3 induced effect of p38 phosphorylation was enhanced by 
the cortisol treatment as it had higher phosphorylated p38 when compared to the anti-CD3 
stimulated MPA and progesterone treated cells. In the hormone only stimulations the 
progesterone only treated cells had lower p38 phosphorylation compared to the cortisol, MPA 
and NET only treated cells. None of the differences that were observed reached a level that 
was significantly different. On day 6 (figure 3.40c) the anti-CD3 stimulated cortisol treated 
cells had significantly higher phosphorylated p38 when compared to anti-CD3 stimulated 
cells. The addition of cortisol enhanced the anti-CD3 induced effect on p38 when compared 
to the p38 phosphorylation of anti-CD3 stimulated cells where MPA, progesterone and NET 
was added to the cells.  
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Day 3 (figure 3.40b) no significant differences were seen in the levels of phosphorylated p38. 
Day 6 (figure 3.40d) the addition of cortisol, MPA, progesterone and NET to BCG stimulated 
cells significantly suppressed the p38 phosphorylation.  
 
Figure 3.40: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on p38 
MAP kinase phosphorylation.  
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, and b indicate statistical significance, where 
values with the same letter are not significantly different from each other.  A P value of 0.05 was regarded as 
significantly different. 
 
vii. JNK 
 
Day 3 (figure 3.41a) no significant differences were seen for the anti-CD3 induced effects on 
phosphorylation of JNK. Day 6 (figure 3.41c) MPA significantly suppressed the JNK 
phosphorylation in anti-CD3 stimulated cells when compared to the effect of cortisol and 
NET treatment on anti-CD3 stimulated cells. The four hormone only stimulations produced 
overall less JNK than the anti-CD3 induced effects.  
On day 3 (figure 3. 41b), no significant differences were see for the BCG induced effects on 
phosphorylation of JNK. Day 6 (figure 3.41d) the level of phosphorylated JNK was 
significantly suppressed by the addition of cortisol, MPA, progesterone and NET to BCG 
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stimulated cells. The hormone only stimulations had significantly lower JNK phosphorylation 
when compared to the BCG induced effects in stimulated cells that were comparable to the 
US value.  
 
Figure 3.41: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced on JNK 
phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
 
viii. IĸBα 
 
Day 3 (figure 3.42a) no statistically significant differences were observed for this time point. 
Day 6 (figure 3.42c) the addition of MPA and progesterone to the anti-CD3 stimulations led 
to the significant suppression of the IκBα phosphorylation levels when compared to anti-CD3 
induced enhancement seen by cortisol.  
Post BCG stimulation for both the day 3 and day 6 time points (figure 3.42b, d) no significant 
observations can be made regarding the observed levels of phosphorylated IκBα.  
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Figure 3.42: The effect of cortisol, MPA, progesterone and NET on BCG- and anti-CD3-induced 
on IκBα phosphorylation. 
PBMCs (1x10
6
cells/well) were cultured and stimulated with a MOI of 5:1 M.bovis BCG or 1µg/ml anti-CD3 
respectively, in the presence and absence of 10 μM of the hormones, cortisol, MPA, progesterone and NET. The 
kinase expression was measured in the cell lysates harvested on day 3 and day 6 post stimulation, via a 8-plex 
Luminex panel. The data was analyzed using a one-way ANOVA with a Fisher LSD post hoc test and presented 
as least-squares means and 95% confidence intervals. The letters a, b, c and d indicate statistical significance, 
where values with the same letter are not significantly different from each other.  A P value of 0.05 was 
regarded as significantly different. 
Summary: 
 
The introduction of BCG infection led to the increase in the phosphorylation and activation of 
STAT5A/B, ERK 1/2, p70S6, STAT3, p38 and JNK signalling molecules. Stimulation with 
anti-CD3 caused the inhibition of phosphorylation of p70S6, but led to the increase in 
phosphorylation for STAT3, p38, JNK and IκBα molecules. The addition of hormones led to 
the inhibition of phosphorylation for the kinases and transcription factors. The addition of 
cortisol, MPA, progesterone and NET led to the suppression of STAT5A/B, ERK 1/2, 
STAT3, CREB, p38 and JNK phosphorylation. The addition of hormones to led to the 
increase in p70S6 phosphorylation in the presence of MPA, progesterone and NET. IκBα 
phosphorylation of the anti-CD3 induced production was increased in the presence of 
cortisol, progesterone and NET but suppressed in the presence of MPA, progesterone and 
NET only. For the signalling pathways the synthetic progestins exhibit actions that mimic the 
glucocorticoid activity seen in cortisol, however at times the synthetic progestins exerts 
progestogenic activity seen in progesterone treated cells.  
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Chapter 4: Discussion 
 
4.1 Effect of hormones on cytokine secretion in BCG infected PBMCs 
 
The aim of the project was to investigate the immune modulatory properties of the synthetic 
progestins MPA versus NET. Both of these synthetic progestins were designed to mimic the 
endogenous hormone progesterone, but only MPA possesses selective glucocorticoid activity 
(52). To achieve this aim PBMCs from non-hormone contraceptive users were stimulated 
with BCG and CD3 in the presence of high concentrations (10
-5
 M) of cortisol, MPA, 
progesterone and NET. The effects of MPA and NET were compared to the endogenous 
hormones cortisol and progesterone, as MPA binds with a high affinity to and activates both 
the glucocorticoid and progesterone receptors. The inhibitory effect of glucocorticoids on 
inflammatory proteins is proposed to be primarily mediated through trans-repression. The 
decrease in transcription through the occurrence of trans-repression has been reported  for a 
number of cytokines and chemokines which include IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-9, 
IL-11, IL-12, IL-13, IL-16, IL-17, IL-18, TNFα and GM-CSF, IL-8, MIP-1α, MCP-1, MCP-
3, MCP-4 and eotaxin (31). This study shows that the presence of the hormones, cortisol and 
MPA, altered the BCG induced and CD3 induced cytokine secretions of IL-1α, IL-1β, IL-6, 
IL-10, IL-12p40, IL-12p70, IL-13, IFN-γ, and TNF-α. Progesterone and NET did not show 
the same degree of inhibition in cytokine secretion as was seen with cortisol and MPA. The 
presence of cortisol, MPA, progesterone and NET enhanced the secretion of G-CSF, possibly 
through trans-activation via a GRE. These results suggest that MPA has the potential to alter 
cytokine expression to the same extent as cortisol, whereas NET seems to mimic 
progesterone rather than cortisol. 
From my stimulations it was seen that cortisol and MPA in both the BCG induced and CD3 
induced cytokine secretions at both the day 3 and day 6 time points showed inhibition of 
cytokine secretions for IL-1α, IL-1β, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, IFN-γ and 
TNF-α. This has the potential to affect the immune response of MPA users during infectious 
diseases, as the inhibition of cytokines secretion during infection could prove to be 
detrimental to the host, as cytokines play a key role in the immune response. 
 
The inhibitory effect that glucocorticoids exhibit on cytokine secretion has been shown 
previously in the following cytokines IL-2, IFNγ, IL-1β, IL-8, TNFα, IL-4, IL-5, IL-6, IL-10, 
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IL-13, IL-17 as well as G-MCSF, where the addition of DEX inhibited the PHA induced 
cytokine secretion in whole blood supernatants (69) . The inhibition of IL-1α, IL-17, IL-6, 
IL-2, IFN-γ, IL-5, GM-CSF, MIP-1β secretion by the hormones, cortisol and MPA but not 
progesterone, in BCG induced stimulations was shown previously (67).  It has been shown 
that DEX and MPA leads to GR-mediated trans-repression of the IL-2 promoter in human 
lymphocytes (58). The effect of DEX and MPA in human lymphocytes stimulated with 
phorbol ester and ionomycin, displayed that DEX and MPA inhibited the phorbol ester and 
ionomycin induced IL-6 and IL-2 production, whereas progesterone only partially inhibited 
the secretion of IL-2 and IL-6 (58). The inhibitory effect of MPA is therefore just as strong as 
DEX whereas progesterone had little immunosuppressive effect compared to that of MPA.  
 
MPA was synthesised to resemble progesterone, however it possess selective GC properties, 
thus it not only binds with a high affinity to the PR but also to the GR (70). NET has 
negligible binding affinity for the GR in comparison with MPA (70). The binding affinity of 
MPA to the GR could be the reason why it inhibits the induced cytokine production of IL-1α, 
IL-1β, IL-6, IL-10, IL-12p40, IL-12p70, IL-13, IFN-γ, and TNF-α, as was also observed for 
cortisol in my results. In my experiments the secretion of G-CSF was enhanced in PBMCs 
stimulated with BCG, together with cortisol when compared to the BCG only response. This 
result confirms previous observation (67). In progesterone and MPA stimulated endometrial 
stromal cells, the enhancing effect in G-CSF production was observed previously (71). 
In my study an inhibition of the BCG and CD3 induced cytokine production by cortisol and 
MPA in IFN-γ, IL-12, IL-1, IL-6, IL-10 and TNF-α was seen. The inhibition of these cytokines 
can be detrimental to the wellbeing of MPA users. The following studies show the role of 
the different cytokines within the immune response. 
i. IFN-γ 
 
The part that IFN-γ plays with regard to M.tb infection is the ability of IFN-γ to activate the 
macrophages capability to inhibit the growth of mycobacteria (3). IFN-γ stimulates the 
release of TNF-α which assists in the inhibition of the mycobacterium, by the production of 
ROS from the IFN-γ activated macrophages (21). It has been found that individuals who 
present with lower levels of IFN-γ and IL-12 have a larger risk of acquiring active disease 
(4). A study done on patients who had been radiographically classified as presenting with 
severe clinical disease exhibited low levels of circulating IFN-γ  in peripheral blood that was 
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associated with a severe state of disease (20). Within my study results I see that the secretion 
of IFN-γ is inhibited by cortisol and MPA in both the CD3 and BCG stimulated cells. The 
inhibition on the secretion of IFN-γ is not seen with progesterone and NET. This indicates 
that in the case of IFN-γ, MPA possesses the immunosuppressive effects similar to cortisol. 
This suppression of IFN-γ in response to mycobacteria could render women using MPA more 
susceptible to mycobacterial diseases including TB. 
ii. IL-12 
 
IL-12 plays a role in creating and maintaining the host’s protective immune response (14). It 
has been shown that IL-12 plays an important role in TB, as individuals with a congenital 
defect in IL-12p40 or in the β1 subunit of the IL-12 receptor, have an increased susceptibility 
to mycobacterial infections (14).  
A study was done in a murine model to determine the importance of IL-12 within the context 
of M.tb infection (16). Administration of IL-12 therapy to CD4
-/-
 mice after M.tb infection, 
revealed a reduced bacterial burden in the lungs of the mice along with an increase in the 
overall survival. This alludes to the fact that IL-12 is beneficial in infectious disease models 
that require a Th-1 immune response (16). The model showed that the administration of IL-
12 therapy increased the expression of IFN-γ at an early time point, 10 days post M.tb 
infection. However after 1 month there was a notable reduction in the frequency and number 
of IFN-γ producing T-cells present in the lungs. This led to the hypothesis that the initial peak 
in IFN-γ production from the exogenous IL-12 may be the cause of the overall enhanced 
outcome of the CD4
-/-
 mice (16). 
In another murine study, an IL-12p40
-/- 
mouse model infected with M.tb was used to 
determine the capability of the mice to control the bacilli and determine the effects of the 
knock out on the immune response (17). The absence of IL-12p40 resulted in the uninhibited 
growth of M.tb bacilli in all target organs after a systemic infection. The growth correlated 
with a reduction in the expression of mRNA of IFN-γ, this was also reflected in the decrease 
in nonspecific as well as antigen specific IFN-γ protein production. The lack of IFN-γ 
production was linked to the delay in producing antigen specific T-cell activation within the 
mice (17). They concluded that IL-12 plays a key role in the generation of antigen-specific T 
cells that are able to produce IFN-γ. From the experiments conducted they projected that the 
initial interaction of the bacilli with the host induces IFN-γ production. The amount of IFN-γ 
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that is produced is dependent on IL-12 and TNF-α. A large production of IFN-γ is necessary 
to induce the expression of the IL-12Rβ2 chain on naïve T cells. The expression of the 
receptor on the naïve T cells is needed for the T cells to act in response to the IL-12 and thus 
become antigen-specific IFN-γ producing cells (17). A study conducted in individuals with 
genetic defects in their IL-12/IL-23/IFN-γ system, found that the system deficiencies 
selectively enhanced their susceptibility to mycobacteria. This led to the conclusion that the 
IL-12/IL-23/IFN-γ system plays an important role in immunity against mycobacteria (72). In 
my results the BCG induced secretion of IL-12p40 and IL-12p70 were inhibited in by the 
addition of cortisol and MPA in the stimulations. The inhibition was not seen with NET. 
Thus women using MPA might have an increased susceptibility to M.tb infection, as a result 
of the inhibition of IL-12.  
iii. IL-1 
 
IL-1 is essential for the control of M.tb infection, however the regulation in vivo of the two 
IL-1 isoforms, IL-1α and IL-1β, and their exact role are not clearly defined (73). Guler et al. 
studied the role of IL-1α and IL-1β in chronic infection with M.tb and spontaneous 
reactivation of it in a mouse model. Blocking IL-1α, but not IL-1β, leads to an increased 
susceptibility to chronic infection with M.tb (74). When neutralizing IL-1α or IL-1β alone, 
there was no observed increase in the reactivation of latent tuberculosis in the mice. The 
generation of antibodies neutralizing IL-1α and IL-1β simultaneously led to an observed 
increase in the lung bacilli count when compared to the immunized control group. These 
results suggested that IL-1α is the prime mediator of the IL-1RI-dependent and protective 
innate immune responses to M.tb in mice (74). During my study the addition of cortisol and 
MPA led to the significant inhibition of both IL-1α and IL-1β in the BCG and CD3 
stimulated cells. The GC inhibiting effect on IL-1 production has been shown previously in 
whole blood where the addition of DEX resulted in the inhibition of LPS induced IL-1 
production (75). In PBMCs stimulated with BCG at both time points, cortisol significantly 
inhibited the secretion of IL-1β (67). This confirms my results. Thus it can be speculated that 
the use of MPA with the associated decrease in IL-1 could potentially lead to the increased 
susceptibility to M.tb infection and poor bacilli control as was seen in the murine model (74). 
 
  
Stellenbosch University  http://scholar.sun.ac.za
124 
 
iv. IL-6 
 
It is known that monocytes respond to M.tb stimulation by producing IL-6, TNF-α, IL-1β and 
IL-10. However, the addition of glucocorticoids inhibits the production of IL-1, IL-6, IL-10, 
IL-13, IFNγ, and TNFα (69). IL-6 is also critical for immunity against M.tb. The increased 
susceptibility to M.tb of the IL-6 deficient mice seemed be associated with a deficient IFNγ 
production during the early phase of infection. A correlation has been found in TB pleural 
patients showing a positive association between levels of IL-6 and IL-1β with IFNγ 
concentrations in their peripheral and pleural compartments respectively (76). The inhibition 
of the cytokine production in my experiments was observed for both time points, the BCG 
induced and CD3 induced IL-6 secretion was inhibited by cortisol and MPA addition. 
Progesterone and NET had negligible inhibition on the BCG and CD3 induced IL-6 secretion. 
The lack of IL-6 with MPA users can potentially increase susceptibility to M.tb infection, this 
fits with the decrease in IL-1 also associated with MPA.  
v. IL-10 
 
IL-10 is produced by macrophages and T lymphocytes during M.tb infection, and is 
considered to primarily be an inhibitory cytokine, important for limiting inflammatory 
responses which could result in immunopathology. IL-10 down-regulates effector functions 
of monocytes/macrophages and DCs and reduces inflammatory responses by inhibiting the 
expression of MHC class II molecules, phagocytosis, the production of NO and reduces the 
production of the pro-inflammatory cytokines IL1β, IL-8, IL-12, IFNγ and TNFα. It has been 
shown previously that mice deficient in IL-10 display unregulated inflammatory responses 
when exposed to LPS. This reveals the key role of IL-10 in keeping a balance in the immune 
system and in protecting the host from excessive immunopathology (77). Another study 
showed that an increase in IL-10 levels appears to support the mycobacterial survival in the 
host. Mice with defective IL-10 exhibit an increase in the anti-mycobacterial immunity (78). 
Beamer et al. conducted a mouse study that found that IL-10 reduces the protective response 
to M.tb in the CBA mouse strain, in which IL-10 is produced by phagocytes in the interior of 
the pulmonary lesion, where a reduction in the TNF and IL-12p40 expression can be 
observed (79). This was also seen in human PBMCs where it was shown that IL-10 inhibits 
the expression of IL-12p40 in PBMCs at transcriptional level. Thus IL-10 restrains clearance 
of the pathogen causing chronic infection (80). The inhibition of the cytokine production was 
seen in my study at both time points, for the BCG induced and CD3 induced IL-10 secretion 
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by cortisol and MPA addition. Thus the decrease in IL-10 secretion by MPA suggests that 
MPA has an overall inhibitory effect and affects Th-1 and Th-2 responses. 
vi. TNF-α 
 
Lymphocytes, endothelial cells and the monocytes and macrophages are all target cells for 
the immunosuppressive and anti-inflammatory actions of the GCs.  The immunosuppressive 
effects on the monocytes and macrophages include the inhibition of IL-1β and TNF-α 
secretion (81). Joyce et al. showed that stimulation with DEX led to the inhibition of TNF-α 
and IL-lβ secretion from monocytes as well as suppressed the secretion of sTNF-R75, sTNF-
R55 and IL-lra (81). TNF-α blocking has dramatic effects on the progression of tuberculosis 
in experimental models. Neutralization of TNF-α in murine models results in tuberculosis 
reactivation (82). Studies have also revealed that TNF-α is expressed in M.tb infected tissues 
during the latent phase of infection, suggesting a contribution, with other cytokines like IFN-
γ, in the control of the bacteria (83). The immunosuppressive effect of cortisol and MPA on 
the BCG induced production of TNF-α, but not progesterone has been shown in PBMCs (67). 
This confirms the inhibition of TNF-α secretion by cortisol and MPA in the BCG induced 
and CD3 induced stimulations seen during my study. Progesterone and NET showed 
negligible inhibition of TNF-α in the BCG induced stimulations, this confirms the result seen 
by Kleynhans et al. During mycobacterial infection the TNF-α plays a key part in the host 
protective response by activating macrophages along with IFN-γ, TNF-α is mostly involved 
in the bacterial control and the formation of granuloma lesions (84). The inhibition of TNF-α 
in MPA users will be detrimental upon contact with infectious diseases, as the lack of TNF-α 
will prevent the macrophages from functioning optimally. 
4.2 Effect of hormones on receptor expression levels in BCG infected PBMCs 
 
The aim was to investigate the presence of the various receptors GR, PR, AR, mPR-α, mPR-
β, mPR-γ and PGRMC1 in the PBMCs, to determine whether they can be potential targets for 
the binding of the endogenous hormones as well as the synthetic progestins. The role of GCs 
in the immune system is to modulate a wide variety of immune cell functions, the expression 
of cytokines, adhesion molecule expression, immune cell trafficking and the maturation, 
differentiation and production of inflammatory mediators (85). One general action of GCs is 
the suppression of inflammatory responses.  
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Glucocorticoids can diffuse across cell membranes where they are able to bind to GRs 
located in the cytoplasm. The GR binds to the chaperone molecules such as Hsp90, resulting 
in no signal transmission (27). Once ligand has bound to the GR, the GR changes its 
conformation and it will dissociate from the chaperone molecules revealing the nuclear 
localization signal of the receptor. The ligand-receptor complexes dimerize, and translocate 
to the nucleus where they can bind to GREs in the promoter regions of GR regulated genes 
where they are capable of altering the expression of steroid-sensitive genes in various ways 
(31). Upon the binding of the receptor homodimer to the GREs an increase in gene 
transcription occurs, known as trans-activation. A monomeric ligand-receptor complex 
changes gene expression through the process of protein to protein interactions with 
transcription factors which is referred to as trans-repression (27). The GR is associated with 
the TCR complex by direct protein-protein interaction with Lck/Fyn. In the presence of a GC 
the GR changes its conformation and dissociates from the TCR complex thereby inhibiting 
the TCR signalling (33). 
.  
i. GR 
 
GR protein was detected in normal human lymphocytes as well as GR mRNA levels in 
lymphocytes and in Jurkat cells (58). The authors wanted to determine whether the 
dissociative GC-like effects of MPA (i.e .strong trans-repression, weak trans-activation) in 
human lymphocytes could also be seen in the other steroid receptors like PR and AR. MPA 
treatment produced noticeable trans-repression of IL-2 gene expression similar to that of 
hydrocortisone and DEX in the human lymphocytes and in Jurkat cells. While the MPA-
mediated trans-activation of pGL3-GRE-tk81-luciferase, a DEX-inducible GRE-dependent 
promoter, was found to be minimal. However, based on the expression studies the authors 
concluded that the observed effects of MPA were mediated by GR, as in human lymphocytes 
they only detected GR at protein level in the cells, but not PR or AR (58). Some reports of 
increased GR levels, have been linked to an increase in the efficacy of ligand. However, it is 
speculated that the increase in GR concentration will result in enhanced potency of GR-
mediated transcription (86). In addition, a shift from non-cooperative to positive cooperative 
ligand-binding as GR levels increase has also been shown in vitro, which would suggest an 
increase in affinity. However, the relationship between GR levels and ligand-binding affinity 
is controversial with some studies have indicated that increased GR levels result in increased 
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affinity, while others find a decrease in affinity (86). My study results I was able to detect the 
GR at both mRNA level as well as protein level. The detectable mRNA of the CD3 
stimulated cells treated with cortisol and MPA at day 3 where higher than those treated with 
progesterone and NET, indicating that cortisol and MPA up-regulate GR levels. Whether the 
up-regulation that is seen is due to the increase in GR levels or the efficacy of the cortisol and 
MPA as ligand, needs to be determined. The decrease in the cytokine expression suggests that 
the cortisol and MPA must have interacted with the GR to induce the immune modulatory 
effects that are seen in the inhibition of cytokine expression. This is also evident in the 
downstream signalling molecules that are also inhibited with the addition of cortisol and 
MPA to stimulated cells for example, Lck, ZAP-70, LAT, STAT3 and JNK all show decrease 
in phosphorylation levels. 
 
ii. PR 
 
Progesterone elicits a variety of functional effects on immune cell types representing multiple 
hematopoietic lineages including alteration of cytokine gene transcription, change in ion 
transport, and inhibition of nitric oxide production (87). PR expression within human 
lymphocytes, which would be a requirement for any PR-mediated effect, is debatable. No 
detectable PR at mRNA or protein levels was found within unstimulated or stimulated human 
lymphocytes. It was thought that if PR is expressed in the human lymphocytes the levels are 
too low to apply any significant effect (58).  A comparative study conducted between infants 
and adults found that, mPR-α, and mPR-γ mRNA levels were present at higher levels in cord 
blood mononuclear cells (CBMCs) than in adult PBMCs, while PGRMC1 was found only in 
CBMCs. The mRNA levels of PR were not detected in CBMCs nor the adult PBMCs, thus 
suggesting that progesterone acts through membrane PRs in CBMCs and PBMCs (68). In 
contradiction with the findings of Bamberger et al. (58)and Giannoni et al.(68) others found 
the PR was detectable at protein level in the cells by Western blot (88) However, my findings 
can corroborate the abovementioned findings, as I also could not detect the PR at protein 
levels in the PBMCs. The level of expression is too low for the detection limit of the Western 
blot. The PR levels were however detectable at mRNA level, though the levels of detection 
were low. This suggests that the signalling via the PR is not necessarily through the nuclear 
receptor but rather through the membrane receptors. 
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iii. AR 
 
 Bamberger et al., found that the lymphocytes expressed AR at mRNA level, but the AR 
protein expression was found to be below the detection limit of Western blot experiments. 
This led them to conclude that AR does not play a role in facilitating the effects of MPA in 
human lymphocytes, as its expression is below the detection limit of Western blot used. Their 
experiment done using dihydrotestosterone, a stronger AR agonist than MPA, had no effect 
on IL-2 promoter activity in the lymphocytes (58). From my study results it can be seen that 
the NET only stimulation had high expression level of AR at both day 1 and day 3. This 
increase in AR expression levels could be due to the progestin NET being structurally related 
testosterone (89). As testosterone has the ability to bind to the AR, the similarities in structure 
could be why the stimulation with NET displayed an increase in the expression of the AR. 
iv. mPR’s 
 
Studies propose that progesterone acts on immune cells through a non-genomic mechanism, 
likely at or near the plasma membrane. Studies done in human peripheral blood cells and 
isolated T cells from female donors and Jurkat cells showed expression at mRNA level for 
mPRα and mPRβ, but not mPRγ nor PR (46). Contradicting results were reported by Chien et 
al., observing mRNA levels in peripheral blood cells from male donors for mPRα, mPRβ, 
and mPRγ (90). In a study it was found that the radiolabeled progesterone bound to the cell 
membranes of T lymphocytes and Jurkat cells with an affinity suitable for steroid receptor 
binding (46). The addition of progesterone to Jurkat cells lead to the activation of an 
inhibitory G protein. Many of these effects occur in cells that seemingly lack PR, potentially 
implicating mPRs as the signal initiators. However, limited research put forward that 
progesterone binding to mPRs produces functional effects in immune cells similar to those in 
Jurkat T cells, where progesterone stimulates the activity of inhibitory G proteins (46). The 
mPR-α has shown no progestin induced signalling changes no cAMP decrease, no ERK 1/2 
activation and calcium mobilization. However, G-protein coupling has been seen in 
myometrial cells (reviewed in (48)). Human mPRs appear to not signal through ERK1/2 but 
activate p38 MAPK. Though, this speculation was only based on the observation that 
treatment of cultured human myometrial cells with cell-impermeable progesterone-BSA led 
to rapid phosphorylation of p38, but not ERK1/2 (45). In my study I showed that the NET 
had high mRNA levels for mPRα, mPRβ and mPRγ at day 1 and day 3. MPA had high 
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mRNA levels for mPRα and mPRβ at day 3, mPRγ showed very high mRNA levels at day 6. 
Progesterone showed high mRNA levels for mPRα, mPRβ and mPRγ throughout day 1,3 and 
6. The CD3 and hormone stimulations, had overall lower expression for all three mPR 
mRNA levels. Whereas, the three hormones, MPA, progesterone and NET, on their own 
showed an increase in mRNA levels detected for the mPRs. This could indicate that the 
hormones by themselves can signal via the membrane receptors without the stimulatory 
condition required, such as BCG and CD3. Both of the signalling molecules speculated 
within the literature to play a role in the signalling of mPRs, ERK 1/2 and p38 where 
inhibited by MPA, progesterone and NET within my findings. The inhibition of these 
signalling molecules indicates a decrease in the phosphorylation of the signalling molecule 
and the kinase remaining inactive. This could imply that in blood cells the mPRs do not 
signal the same way as is speculated in the breast cancer and reproductive cell models.  
v. PGRMC1 
 
In a porcine model the expression of PGRMC1 was looked at in the liver cells. It was found 
that although progesterone bound with highest affinity among the steroids tested to the 
PGRMC1.From the EC50 it could be seen that cortisol exhibited 4% of the observed binding 
affinity. The authors suggests that under physiological conditions in the liver cells the 
PGRMC1 binding could be occupied with cortisol rather than progesterone due to the higher 
circulating concentration of cortisol (91). It has been reported previously that the PGRMC1 
possesses a GRE, however it does not have a PRE (92). It has been suggested previously that 
women who have pre-existing breast cancer cells overexpressing PGRMC1 have an increased 
risk of developing breast cancer when receiving hormone therapy composed of estrogen or 
estrogen and progesterone combined (89). The type of progestogen used within the treatment 
seems to play a role. Using a progestin that is related structurally to testosterone for example 
NET, seem to be more tumorigenic than Progesterone related derivatives like MPA, which 
are less likely to stimulate the development of precancerous cells to tumors. The authors 
obtained these results by using cells that expressed raised levels of exogenous PGRMC1 (89). 
It can be seen from my results that at day 3, that the levels of detectable mRNA for MPA, 
progesterone and NET are high, as well as the progesterone CD3 induced levels of mRNA for 
PGMRC1.  This remains the case at day 6, however now it is no longer the progesterone CD3 
induced levels that are high, but rather the cortisol CD3 induced levels, with cortisol having 
the largest mRNA level in comparison with MPA, NET and progesterone. As it has been 
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shown previously in breast cancer cells that the synthetic progestins do bind to PGRMC1, 
this could be the scenario within the PBMCs as well, that the hormones bind to the PGRMC1. 
The increase in the mRNA levels in the presence of cortisol could potentially be due to the 
GRE found in the PGRMC1, or could potentially be attributed to the fact that cortisol can 
bind to the PGRMC1 thus could possibly signal through this receptor. 
4.3 Effect of hormones on phosphorylation of signalling molecules in BCG 
infected PBMCs 
 
The aim of the study was to investigate the effect of the endogenous hormones, cortisol and 
progesterone, and synthetic progestins, MPA and NET, on the BCG induced and CD3 
induced phosphorylation of signalling molecules. Kinases phosphorylate proteins and 
phosphatases dephosphorylate proteins. Many enzymes and receptors are turned "on" or "off" 
by the process of phosphorylation and de-phosphorylation. Reversible phosphorylation 
results in a conformational change in the structure seen in many enzymes and receptors, 
causing them to become activated or deactivated. Phosphorylation usually occurs on serine, 
threonine, tyrosine and histidine residues in the protein molecules (93). 
i. Lck 
 
Lck is a protein found within lymphocytes. Lck is a tyrosine kinase and a member of the Src 
family, Lck phosphorylates the tyrosine residues of some of the proteins involved in the 
intracellular signalling pathways of the lymphocytes. Harr et al., has shown that Lck protects 
cells from glucocorticoid induced apoptosis. In the T cells it was found that the Lck was 
downregulated by DEX and thus inhibits TCR activation (94). It has also been shown that 
glucocorticoids rapidly inhibit Lck by a non-genomic mechanism involving the interaction 
between the TCR complex and the ligand bound GR (33). Differences in the phosphorylation 
patterns of DEX-treated and non-DEX-treated cells, showed there was a decrease in 
phosphorylation of Lck/Fyn substrates in the DEX-treated group as well as an impairment of 
recruitment of these substrates to the TCR (33). Harr et al., was the first to show that DEX 
downregulate, Lck transcripts as well as protein levels in a GR-dependant way (94). 
Numerous proteins forming part of the TCR signalling pathway were downregulated by 
DEX, ZAP-70 protein levels were decreased 24hours post DEX treatment, they found LAT 
protein to be downregulated too. This led to the conclusion that glucocorticoids are capable 
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of inhibiting the TCR signalling pathway by negatively regulating proteins in the pathway 
(94). From my study it can be seen on day 3 and day 6 that the addition of hormones 
(cortisol, MPA, progesterone and NET) to BCG had lower Lck phosphorylation levels than 
compared to the US sample group. Day 3 the CD3 induced phosphorylation levels of cortisol 
and cortisol on its own were inhibited more than was seen by MPA, progesterone and NET. 
However, by day 6 the CD3 induced Lck phosphorylation was significantly inhibited by 
cortisol, MPA, progesterone and NET, as well as cortisol, MPA, progesterone and NET. The 
initial signalling data at Day 1 showed no differences amongst stimulations. My results do 
not reflect the rapid non-genomic inhibition of TCR as was seen by Lowenberg et al. as my 
time points that were selected were too late. The possibility of a genomic effect is plausible 
as the effects of inhibition of phosphorylation are seen on day 3 and day 6 for CD3 
stimulations. However, absent at day 6 in the BCG stimulations. CD3 stimulations were done 
specifically to activate the TCR signalling cascade, whereas BCG was chosen as a 
nonspecific antigen. Thus the lowering of Lck in the hormones treated cells stimulated with 
CD3 can be a result of genomic interactions of the hormones.  
ii. ZAP-70 
 
ZAP-70 is a member of the protein-tyrosine kinase family, it is a protein that is expressed 
near the membrane of T cells and natural killer T cells. It forms part of the TCR, and plays an 
important role in T-cell signalling. In Jurkat cells short term DEX exposure led to the 
phosphorylation of ZAP-70, and enhanced the association between the ZAP-70 and GR as a 
result of non-genomic glucocorticoid effects. It was also observed that the DEX exposure 
decreased the CD3 induced phosphorylation of ZAP-70 (95). In P116 cells (ZAP-70-deficient 
Jurkat subclone) that were lentivirally-transfected with wild type or point-mutated ZAP-70 
constructs were exposed to a short term, high dose DEX treatment. Led to decrease in ZAP-
70 phosphorylation in the 315-tyrosine and 492- tyrosine ZAP-70 expressing cells. This 
alluded to the involvement of these two tyrosine residues of the ZAP-70 kinase to be 
involved in the non-genomic GC signalling (96). Studies in antigen-specific murine CD4+ T 
cells and primary human T cells and found that M.tb cell wall glycolipids, mannose capped 
lipoarabinomannan (ManLAM) inhibited ZAP-70. Phosphorylation of signalling proteins 
were inhibited both upstream (Lck) and downstream (LAT) of ZAP-70 were inhibited by 
ManLAM (97). From my study it can be seen that at day 3 both the BCG induced and CD3 
induced ZAP-70 phosphorylation levels were lowered by cortisol, compared to day 1 where 
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there was no decrease in the ZAP-70 phosphorylation observed in the CD3 induced results. 
Although my experiments were not short term exposure but long term (3 day) exposure I saw 
the same effect as was seen in high dose short term DEX exposed P116 Jurkat cells. Cortisol 
decreased the phosphorylation of the ZAP-70 as well as its upstream and downstream, Lck 
and LAT, signalling molecules. The decrease in the phosphorylation of ZAP-70 was not seen 
by MPA but NET. 
iii. LAT 
 
LAT is a membrane adapter protein that links the early biochemical events with the 
downstream signalling cascades needed for the activation of the MAPK cascade and the 
activation of ERK (98). Boldizsar et al., showed that LAT displayed increased 
phosphorylation after short term DEX exposure, this suggests the involvement of LAT in 
transmission of the non-genomic effects associated with ZAP-70 and downstream targets 
(96). Point mutations induced in ZAP-70 determined the downstream signalling effects, none 
of which affected the phosphorylation of LAT, this led them to conclude that the LAT was 
not involved in the non-genomic signalling of ZAP-70 (96). LAT can not only be 
phosphorylated by the ZAP-70 kinase, but also by Lck and it might be possible that non-
genomic GC effects of LAT are induced through those molecules. The short term DEX 
exposure results are in contradiction with my results were I saw that at day 3 the CD3 
induced LAT phosphorylation levels were significantly decreased by the addition of cortisol. 
The same effect was seen for the addition of NET. The androgenic effect of NET seemed to 
mimic GC effect seen in cortisol. Whereas MPA and progesterone had higher 
phosphorylation of LAT, than was observed for cortisol and NET. Day 3 of the BCG 
stimulations showed a decrease in LAT phosphorylation by cortisol and progesterone and, 
higher LAT phosphorylation by the synthetic progestins.  
iv. STAT3 
 
Zhang et al. through their transfection studies found a central role of STAT3 in 
synergistically enhancing glucocorticoid signalling (99). They hypothesised that STAT3 
could interact directly with the GR, thus improving the trans-activation of each component 
through its responsive element. Through their co-immunoprecipitation experiments they 
identified that the STAT3-GR complex could be detected only in extracts acquired from cells 
co-stimulated with IL-6 and DEX (99). They were able to demonstrate the formation of a 
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STAT3-GR complex which was able to bind to the IL-6RE. They concluded that STAT3 acts 
as a potent co-activator of GRE-mediated transcription, independent of IL-6RE binding. 
Their findings reveal an interaction between IL-6 and GC signalling pathways, and could 
suggest that STAT3 may modulate other GC actions (99). 
The synergistic relationship between GR and STAT3 was also seen by Unterberger et al 
(100). They wanted to find the possible mechanism leading to the involvement of STAT3 in 
GC induction of IL-10 gene expression, and whether the GR was involved. They found that 
using the synthetic steroid RU486 which is a GR and PR antagonist, they could completely 
block the IL-10 mRNA synthesis. This led to the deduction that there is a possibility that the 
GR directly interacts with the STAT3. This synergistic action is mediated by interaction of 
the GR protein with the STAT3 protein. One possible way this is achieved is by the binding 
of the GR to STAT3 as this will stabilize its DNA binding and retention in the nucleus. This 
implies that STAT3, transferring between cytoplasm and nucleus, is confined by its 
connection to the GR. Another option is that the GR leads to enhanced serine 
phosphorylation of STAT3 with subsequent nuclear translocation of STAT3 homodimers. 
Such as non-genomic mechanisms of GCs acting via the GR has been shown in PI-3 kinase 
and Akt (100). In breast cancer cells it was shown that MPA is able to induce STAT3 
phosphorylation at serine727 and that the c-Src and ERK 1/2 MAPK signalling pathway is 
involved in this phosphorylation event (101). MPA is also able to induce STAT3 
phosphorylation at tyrosine705 through the activation of the c-Src/Jak signalling pathway 
leading to in vivo cyclin D1 up-regulation and breast cancer growth (101). We see that on day 
6 there is a significant decrease in the CD3 induced STAT3 phosphorylation levels in the 
cortisol, MPA, progesterone and NET stimulations. However the cortisol and MPA showed 
lower phosphorylation levels when compared to progesterone and NET. This means that 
there is less activated STAT3, yet in my cytokine data I see that the CD3 induced secretion of 
IL-6 and IL-10 are inhibited at day 6, this could be due to the cortisol and MPA activation of 
GR. The decrease in the cytokine production could potentially be due to the interaction of the 
STAT3-GR complex, and as cortisol and MPA bind with higher affinity to the GR compared 
to progesterone and NET, this could be why we see lower STAT3 levels as it is bound to the 
GR. 
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v. JNK 
 
JNK belongs to the MAPK family, and is responsive to stress stimuli, such as cytokines, 
ultraviolet irradiation, heat shock, and osmotic shock. They also play a role in T cell 
differentiation and the cellular apoptosis pathway. It has been suggested that this signalling 
pathway contributes to inflammatory responses in humans (102). In lung epithelial cells 
rhinovirus infection attenuates GRα nuclear translocation in response to DEX stimulation and 
showed reduced corticosteroid sensitivity. They found that the rhinovirus infection resulted in 
a JNK-dependent increase in GR Ser226 phosphorylation, responsible for the shuttling of 
GRα. They found that JNK-1 isoform activation is involved in rhinovirus-induced 
corticosteroid insensitivity, due to the JNK activation, but not a result of the induction which 
occurs quickly after virus stimulation. JNK activation, rather than increased expression of 
JNK-1, is likely involved in the rhinovirus induced corticosteroid insensitivity observed 
under the experimental conditions (102). Knock down of GR in L929sA cells shows that a 
decline in GR protein can partially revert the negative impact of DEX on STS and TNF-
stimulated JNK phosphorylation, suggesting GR dependence. On day 6 it can be seen that the 
BCG induced JNK phosphorylation was significantly lower with the addition of cortisol, 
MPA, progesterone and NET.  
vi. IκBα 
 
Crinelli et al., found in monocytic cell lines exposed to DEX showed an increase in the 
intracellular concentration of IκBα mRNA and protein. They found that the induction of IκBα 
was activated and deactivated very rapidly both at the mRNA and protein levels (103). They 
suggested that the down-regulation of NF-κB by glucocorticoids can be extered through the 
protein-protein interactions of NF-κB subunits and the GR, or through the induced synthesis 
of IκBα. They concluded that DEX was able to interfere with the activation of the NF-κB 
pathway and modulate TNF-α mRNA synthesis (103).  Although within my results we see 
that on day 6 there is an increase in the CD3 induced IκBα levels with the addition of cortisol, 
however the addition of MPA significantly reduced the CD3 induced IκBα levels. This could 
potentially mean that the addition of cortisol acted in the same way as DEX, but not MPA. 
Within my results you can also see the TNF-α CD3 induced secretion was inhibited by the 
addition of cortisol and MPA, so this does indicate the possibility of the interference of the 
NF-κB pathway activation. 
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vii. CREB and p38 
 
My study indicated that both the time points that the phosphorylation of CREB and p38 was 
inhibited by the addition of cortisol, MPA, progesterone and NET. This could potentially 
indicate that the lack of p38 phosphorylation led to the inhibition of the CREB 
phosphorylation. In the BCG induced stimulations there is no change between the day 3 and 
day 6 CREB or p38 induced profiles. Previous literature has shown that both DEX and 17 
beta-estradiol benzoate (E2b) induce CREB activation in CCRF-CEM cells (104). The 
authors found that both the cAMP antagonist Rp-8-Br-cAMPS, and the p38 MAPK inhibitor 
SB 203580 effectively prevent CREB activation and Annexin 1 (ANXA1) synthesis induced 
by DEX, E2b or the cAMP analogue dBcAMP. These results indicate that cAMP and p38 are 
both required for DEX-induced and E2b-induced CREB activation and ANXA1 synthesis, 
and are also strong evidence that CREB activation is required for ANXA1 synthesis in these 
cells. Both hormones required longer incubation periods for maximal response, suggesting 
that cAMP has to be produced, in response to both steroids, before CREB activation can 
occur in CCRF-CEM cells. The DEX induced and E2b induced ANXA1 expression requires 
the activation of the transcription factor CREB, which in turn seems to be mediated by cAMP 
and the p38. CREB, may play important roles in mediating the anti-inflammatory actions of 
GC and estrogen hormones (104).  
Conclusion 
 
The aim of my investigation was to determine the receptor involvement and the downstream 
signalling molecules affected by the addition of cortisol, MPA, progesterone and NET.  The 
final aim was to determine the cytokine levels to determine whether the synthetic hormones 
mimic the immunosuppressive effect of cortisol, or mimic progesterone which they were 
created to resemble.  
My study indicates that the GR could be detected at protein level in the PBMCs, but the PR 
was not present at protein level. The mRNA levels within the PBMCs indicate that the cells 
have mRNA expression for GR, PR, AR, mPR-α, mPR-β, mPR-γ and PCRMC1 receptors. 
Cortisol that was added to the cell stimulations resulted in an increase in GR expression 
levels. This could indicate that the availability of the ligand, led to the increase in the 
expression of the receptor, or the affinity of the receptor increased for the ligand as was 
suggested earlier. The addition of MPA and progesterone to the PBMCs increased the 
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expression levels of the GR, AR, mPR-α, mPR-β, mPR-γ and PGRMC1. The increase in the 
PR related receptors with the stimulation of MPA and progesterone, could potentially 
indicate that these are the receptors of choice for the signalling to occur through. However, 
both the PR and endogenous GR are present in all the cells, thus we cannot speculate that the 
effect will only be through the mPRs and PGRMC1 as the GR is still available for MPA to 
signal through. As for the membrane receptors and PGRMC1 this occurred for both the CD3 
and BCG mediated expression. The expression levels of the PR were increased by the 
presence of progesterone only in the CD3 stimulations.  
The signalling molecules showed inhibition by the addition of the hormones. The addition of 
cortisol inhibited the phosphorylation of Lck, ZAP-70, LAT, and cortisol increased the 
inhibition in the p70S6, p38 at day 6 and IκBα. Cortisol, MPA, progesterone and NET 
inhibited the phosphorylation of ERK 1/2, STAT3, CREB, p38 and JNK. The inhibition of 
the phosphorylation by the hormones could indicate that the effects seen are the result of the 
genomic effect, as the non-genomic effect is rapid and the effects will not be detectable at the 
later time points. 
The cytokine data indicates that there were immune modulatory effects that occurred within 
the stimulations. The addition of cortisol and MPA led to the inhibition of cytokine secretion 
such as IL-1α, IL-1β, IL-6, IL-10, TNF-α, IL-12 and IL-13. The suppression of the cytokines 
leads to a suppressed immune response upon mycobacterial encounter. Thus women who are 
using MPA as opposed to NET will possibly be more susceptible to infection, have poor 
bacilli control. The suppression of IL-10 will lead to the inhibition of proinflammatory 
cytokines such as IFN-γ, TNF-α and IL-12, thus harmful to the host. The failure to activate 
the secretion of IFN-γ by TNF-α will cause a lowering of the host’s protective response. 
Although we could not see throughout the results that MPA always mimicked cortisol as we 
hypothesised from the cytokine data. The cytokines play a big role in determining the 
outcome of the hosts immune response, thus the inhibition of cytokines by MPA as is seen 
with cortisol suggests that MPA has more glucocorticoid activity than progestogenic activity. 
Whereas NET has negligible inhibition on cytokines, thus acts more like progesterone and is 
more beneficial to use than MPA. Women who are currently undergoing TB treatment, 
cannot use an estrodiol containing contraceptive, thus MPA is recommend due to its 
progesterone properties. Thus, both synthetic progestins MPA and NET will be suitable to 
use during TB treatment. However, it should be recommended to women receiving TB 
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treatment to rather use NET as an alternative to MPA. As NET does not have the selective 
GC activity seen with MPA that results in an altered immune response to TB. 
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Addendum A: Solution Recipes 
 
1) 10x Running Buffer 
288g Glycin 
60,6g Tris 
Final volume is 2,0 litres, with dH20. 
2) 1x Running Buffer 
10x Running buffer 
0,1% SDS 
Final volume is 2,0 litres. 
3) Blotting Buffer 
200ml Methanol 
200ml 1x Running buffer 
Final volume is 2,0 liters 
4) 1x TBS Buffer 
20mM Tris (pH7,6) 
150mM NaCl 
Final volume is 2,0 liters 
5) TBS and Tween 
1x TBS Buffer 
0,1% Tween-20 
Final volume is 1,0 litres  
6) Lysis Buffer (Bradford) 
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10ml Lysis buffer 
1x protease inhibitor tablet 
100µl phosphatase inhibitor (1:100 dilution) 
7) Western Blot Blocking Buffer 
5% fat free milk powder  
20ml TBS 
8) Primary Antibody 
5% fat free milk powder 
20ml TBS 
1:1000 dilution with primary antibody 
9) Secondary Antibody 
5% fat free milk powder 
20ml TBS 
1:5000 dilution with secondary antibody 
10) 5x Laemmli Buffer 
125mM Tris (pH6,8) 
20% Glycerol 
5% SDS 
2,5% Beta-mercaptoethanol 
0,1% Bromophenol blue 
Final volume is 10ml. 
11) Lysis Buffer 
20mM Tris (pH7,6) 
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150mM NaCl 
1mM EDTA 
1% Trton X-100 
Final volume is 100ml 
12) Resolving gel: 8% SDS-Polyacrylamide Gel Electrophoresis 
18,5ml H2O 
10,7ml 30% Acrylamide mix 
10,0ml 1,5M Tris (pH8,8) 
0,4ml 10% SDS 
0,4ml 10% Ammonium persulfate 
0,024ml TEMED 
13) 5% Stacking gel: SDS-Polyacrylamide Gel Electrophoresis 
6,8ml H2O 
1,7ml 30% Acrylamide mix 
1,25ml 1,5M Tris (pH8,8) 
0,1ml 10% SDS 
0,1ml 10% Ammonium persulfate 
0,01ml TEMED 
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